country_code,sex,volume,cancer,rank,cases,py,asr,per1,per2,cancer_label,country_label
208,1,1,10,13,588,10025071,5.23,1943,1947,Lip,Denmark
208,1,1,20,24,175,10025071,1.58,1943,1947,Oral Cavity,Denmark
208,1,1,30,35,76,10025071,0.72,1943,1947,Salivary glands,Denmark
208,1,1,40,29,134,10025071,1.22,1943,1947,Oropharynx,Denmark
208,1,1,41,40,50,10025071,0.46,1943,1947,Nasopharynx,Denmark
208,1,1,50,45,11,10025071,0.1,1943,1947,Hypopharynx,Denmark
208,1,1,60,14,576,10025071,5.18,1943,1947,Oesophagus,Denmark
208,1,1,70,1,4592,10025071,40.74,1943,1947,Stomach,Denmark
208,1,1,80,38,69,10025071,0.62,1943,1947,Small intestine,Denmark
208,1,1,110,19,319,10025071,2.81,1943,1947,Liver,Denmark
208,1,1,120,32,99,10025071,0.91,1943,1947,Gallbladder,Denmark
208,1,1,130,16,415,10025071,3.75,1943,1947,Pancreas,Denmark
208,1,1,140,37,73,10025071,0.67,1943,1947,"Nasal Cavity, middle ear and sinuses",Denmark
208,1,1,150,23,178,10025071,1.61,1943,1947,Larynx,Denmark
208,1,1,160,4,1339,10025071,12.08,1943,1947,Lung,Denmark
208,1,1,170,44,37,10025071,0.34,1943,1947,Pleura,Denmark
208,1,1,180,41,46,10025071,0.43,1943,1947,Breast,Denmark
208,1,1,240,5,1310,10025071,11.5,1943,1947,Prostate,Denmark
208,1,1,250,18,342,10025071,3.09,1943,1947,Testis,Denmark
208,1,1,260,27,140,10025071,1.26,1943,1947,Penis and other male genital organs,Denmark
208,1,1,270,15,439,10025071,4.02,1943,1947,Kidney,Denmark
208,1,1,280,10,681,10025071,6.18,1943,1947,Bladder and urinary tract,Denmark
208,1,1,290,31,111,10025071,0.99,1943,1947,Melanoma of skin,Denmark
208,1,1,300,3,1842,10025071,16.72,1943,1947,"Skin, non-melanoma",Denmark
208,1,1,310,30,118,10025071,1.11,1943,1947,Eye,Denmark
208,1,1,315,46,1,10025071,0.01,1943,1947,Endocrine tumors of brain and CNS,Denmark
208,1,1,316,42,41,10025071,0.38,1943,1947,Meningiomas,Denmark
208,1,1,320,12,613,10025071,5.75,1943,1947,Brain and CNS excluding endocrine tumors,Denmark
208,1,1,321,11,614,10025071,5.76,1943,1947,Brain and CNS including endocrine tumors,Denmark
208,1,1,330,43,42,10025071,0.38,1943,1947,Thyroid,Denmark
208,1,1,340,28,128,10025071,1.24,1943,1947,Bone,Denmark
208,1,1,350,21,204,10025071,1.93,1943,1947,Soft tissues,Denmark
208,1,1,360,20,243,10025071,2.21,1943,1947,Non Hodgkin lymphomas,Denmark
208,1,1,370,25,167,10025071,1.51,1943,1947,Hodgkin lymphomas,Denmark
208,1,1,380,33,92,10025071,0.83,1943,1947,Multiple myelomas,Denmark
208,1,1,390,47,0,10025071,0,1943,1947,Myelodysplastic syndromes,Denmark
208,1,1,392,48,0,10025071,0,1943,1947,Myeloproliferative diseases,Denmark
208,1,1,394,49,0,10025071,0,1943,1947,Other hematopoietic diseases,Denmark
208,1,1,400,9,688,10025071,6.56,1943,1947,Leukaemias,Denmark
208,1,1,401,39,56,10025071,0.59,1943,1947,Acute lymphatic leukaemias,Denmark
208,1,1,402,17,337,10025071,3.14,1943,1947,Chronic lymphatic leukaemias,Denmark
208,1,1,403,50,0,10025071,0,1943,1947,Other and unspecified lymphatic leukaemias,Denmark
208,1,1,404,34,70,10025071,0.73,1943,1947,Acute myeloid leukaemias,Denmark
208,1,1,405,26,152,10025071,1.4,1943,1947,Chronic myeloid leukaemias,Denmark
208,1,1,406,51,0,10025071,0,1943,1947,Other and unspecified myeloid leukaemia,Denmark
208,1,1,407,36,73,10025071,0.71,1943,1947,"Leukaemia, cell unspecified",Denmark
208,1,1,410,22,178,10025071,1.66,1943,1947,Other specified cancers,Denmark
208,1,1,420,8,895,10025071,8.12,1943,1947,Other and ill-defined cancers,Denmark
208,1,1,430,6,1190,10025071,11.11,1943,1947,Malignant haematopoietic diseases,Denmark
208,1,1,510,7,1034,10025071,9.3,1943,1947,"Lip, oral cavity and pharynx",Denmark
208,1,1,520,2,3871,10025071,34.75,1943,1947,Colorectal,Denmark
208,1,10,10,48,53,14388214,0.16,2016,2020,Lip,Denmark
208,1,10,20,24,1153,14388214,4.31,2016,2020,Oral Cavity,Denmark
208,1,10,30,45,198,14388214,0.7,2016,2020,Salivary glands,Denmark
208,1,10,40,18,1579,14388214,6.21,2016,2020,Oropharynx,Denmark
208,1,10,41,47,74,14388214,0.33,2016,2020,Nasopharynx,Denmark
208,1,10,50,37,427,14388214,1.52,2016,2020,Hypopharynx,Denmark
208,1,10,60,17,2100,14388214,6.84,2016,2020,Oesophagus,Denmark
208,1,10,70,16,2323,14388214,7.59,2016,2020,Stomach,Denmark
208,1,10,80,31,644,14388214,2.16,2016,2020,Small intestine,Denmark
208,1,10,110,20,1749,14388214,5.59,2016,2020,Liver,Denmark
208,1,10,120,33,537,14388214,1.8,2016,2020,Gallbladder,Denmark
208,1,10,130,15,2810,14388214,8.87,2016,2020,Pancreas,Denmark
208,1,10,140,42,208,14388214,0.75,2016,2020,"Nasal Cavity, middle ear and sinuses",Denmark
208,1,10,150,25,958,14388214,3.21,2016,2020,Larynx,Denmark
208,1,10,160,4,12094,14388214,36.91,2016,2020,Lung,Denmark
208,1,10,170,34,609,14388214,1.68,2016,2020,Pleura,Denmark
208,1,10,180,43,228,14388214,0.75,2016,2020,Breast,Denmark
208,1,10,240,1,22712,14388214,70.75,2016,2020,Prostate,Denmark
208,1,10,250,14,1580,14388214,10.51,2016,2020,Testis,Denmark
208,1,10,260,39,362,14388214,1.24,2016,2020,Penis and other male genital organs,Denmark
208,1,10,270,12,3444,14388214,12.68,2016,2020,Kidney,Denmark
208,1,10,280,6,8504,14388214,25.61,2016,2020,Bladder and urinary tract,Denmark
208,1,10,290,7,6485,14388214,24.97,2016,2020,Melanoma of skin,Denmark
208,1,10,300,5,10235,14388214,26.38,2016,2020,"Skin, non-melanoma",Denmark
208,1,10,310,41,233,14388214,1.05,2016,2020,Eye,Denmark
208,1,10,315,51,5,14388214,0.03,2016,2020,Endocrine tumors of brain and CNS,Denmark
208,1,10,316,35,421,14388214,1.68,2016,2020,Meningiomas,Denmark
208,1,10,320,9,3992,14388214,17.91,2016,2020,Brain and CNS excluding endocrine tumors,Denmark
208,1,10,321,8,3997,14388214,17.94,2016,2020,Brain and CNS including endocrine tumors,Denmark
208,1,10,330,26,685,14388214,3.05,2016,2020,Thyroid,Denmark
208,1,10,340,40,202,14388214,1.21,2016,2020,Bone,Denmark
208,1,10,350,29,627,14388214,2.42,2016,2020,Soft tissues,Denmark
208,1,10,360,10,4128,14388214,14.55,2016,2020,Non Hodgkin lymphomas,Denmark
208,1,10,370,28,477,14388214,2.68,2016,2020,Hodgkin lymphomas,Denmark
208,1,10,380,21,1635,14388214,5.09,2016,2020,Multiple myelomas,Denmark
208,1,10,390,27,1000,14388214,2.89,2016,2020,Myelodysplastic syndromes,Denmark
208,1,10,392,19,1605,14388214,5.74,2016,2020,Myeloproliferative diseases,Denmark
208,1,10,394,49,35,14388214,0.09,2016,2020,Other hematopoietic diseases,Denmark
208,1,10,400,13,3098,14388214,11.99,2016,2020,Leukaemias,Denmark
208,1,10,401,30,214,14388214,2.21,2016,2020,Acute lymphatic leukaemias,Denmark
208,1,10,402,22,1534,14388214,4.85,2016,2020,Chronic lymphatic leukaemias,Denmark
208,1,10,403,44,192,14388214,0.73,2016,2020,Other and unspecified lymphatic leukaemias,Denmark
208,1,10,404,32,551,14388214,2.03,2016,2020,Acute myeloid leukaemias,Denmark
208,1,10,405,36,447,14388214,1.64,2016,2020,Chronic myeloid leukaemias,Denmark
208,1,10,406,46,114,14388214,0.39,2016,2020,Other and unspecified myeloid leukaemia,Denmark
208,1,10,407,50,15,14388214,0.07,2016,2020,"Leukaemia, cell unspecified",Denmark
208,1,10,410,38,310,14388214,1.41,2016,2020,Other specified cancers,Denmark
208,1,10,420,23,1508,14388214,4.7,2016,2020,Other and ill-defined cancers,Denmark
208,1,10,430,2,11947,14388214,42.95,2016,2020,Malignant haematopoietic diseases,Denmark
208,1,10,510,11,3484,14388214,13.23,2016,2020,"Lip, oral cavity and pharynx",Denmark
208,1,10,520,3,13318,14388214,42.15,2016,2020,Colorectal,Denmark
208,2,1,10,43,53,10216666,0.44,1943,1947,Lip,Denmark
208,2,1,20,30,139,10216666,1.12,1943,1947,Oral Cavity,Denmark
208,2,1,30,36,79,10216666,0.67,1943,1947,Salivary glands,Denmark
208,2,1,40,42,53,10216666,0.45,1943,1947,Oropharynx,Denmark
208,2,1,41,48,20,10216666,0.18,1943,1947,Nasopharynx,Denmark
208,2,1,50,49,10,10216666,0.08,1943,1947,Hypopharynx,Denmark
208,2,1,60,19,318,10216666,2.49,1943,1947,Oesophagus,Denmark
208,2,1,70,2,3691,10216666,29.32,1943,1947,Stomach,Denmark
208,2,1,80,39,70,10216666,0.57,1943,1947,Small intestine,Denmark
208,2,1,110,13,472,10216666,3.74,1943,1947,Liver,Denmark
208,2,1,120,22,251,10216666,2.04,1943,1947,Gallbladder,Denmark
208,2,1,130,16,364,10216666,2.95,1943,1947,Pancreas,Denmark
208,2,1,140,45,47,10216666,0.39,1943,1947,"Nasal Cavity, middle ear and sinuses",Denmark
208,2,1,150,44,51,10216666,0.44,1943,1947,Larynx,Denmark
208,2,1,160,14,405,10216666,3.33,1943,1947,Lung,Denmark
208,2,1,170,47,25,10216666,0.21,1943,1947,Pleura,Denmark
208,2,1,180,1,5145,10216666,42.79,1943,1947,Breast,Denmark
208,2,1,190,4,2957,10216666,24.71,1943,1947,Cervix uteri,Denmark
208,2,1,200,8,1067,10216666,9,1943,1947,Corpus uteri,Denmark
208,2,1,210,21,271,10216666,2.22,1943,1947,"Uterus, other",Denmark
208,2,1,220,7,1268,10216666,10.7,1943,1947,Ovary and tubes,Denmark
208,2,1,227,23,228,10216666,1.88,1943,1947,Vulva,Denmark
208,2,1,228,40,66,10216666,0.52,1943,1947,Vagina,Denmark
208,2,1,229,50,0,10216666,0,1943,1947,Other female genital organs,Denmark
208,2,1,230,20,294,10216666,2.4,1943,1947,"Vulva, vagina and other female genital organs",Denmark
208,2,1,270,15,363,10216666,3.01,1943,1947,Kidney,Denmark
208,2,1,280,18,308,10216666,2.55,1943,1947,Bladder and urinary tract,Denmark
208,2,1,290,29,140,10216666,1.2,1943,1947,Melanoma of skin,Denmark
208,2,1,300,6,1332,10216666,10.78,1943,1947,"Skin, non-melanoma",Denmark
208,2,1,310,35,81,10216666,0.7,1943,1947,Eye,Denmark
208,2,1,315,51,0,10216666,0,1943,1947,Endocrine tumors of brain and CNS,Denmark
208,2,1,316,34,89,10216666,0.75,1943,1947,Meningiomas,Denmark
208,2,1,320,10,581,10216666,5.23,1943,1947,Brain and CNS excluding endocrine tumors,Denmark
208,2,1,321,11,581,10216666,5.23,1943,1947,Brain and CNS including endocrine tumors,Denmark
208,2,1,330,32,122,10216666,0.99,1943,1947,Thyroid,Denmark
208,2,1,340,33,99,10216666,0.92,1943,1947,Bone,Denmark
208,2,1,350,27,184,10216666,1.59,1943,1947,Soft tissues,Denmark
208,2,1,360,24,205,10216666,1.78,1943,1947,Non Hodgkin lymphomas,Denmark
208,2,1,370,31,119,10216666,1.09,1943,1947,Hodgkin lymphomas,Denmark
208,2,1,380,37,73,10216666,0.61,1943,1947,Multiple myelomas,Denmark
208,2,1,390,52,0,10216666,0,1943,1947,Myelodysplastic syndromes,Denmark
208,2,1,392,53,0,10216666,0,1943,1947,Myeloproliferative diseases,Denmark
208,2,1,394,54,0,10216666,0,1943,1947,Other hematopoietic diseases,Denmark
208,2,1,400,12,497,10216666,4.55,1943,1947,Leukaemias,Denmark
208,2,1,401,46,36,10216666,0.38,1943,1947,Acute lymphatic leukaemias,Denmark
208,2,1,402,25,189,10216666,1.7,1943,1947,Chronic lymphatic leukaemias,Denmark
208,2,1,403,55,0,10216666,0,1943,1947,Other and unspecified lymphatic leukaemias,Denmark
208,2,1,404,41,58,10216666,0.51,1943,1947,Acute myeloid leukaemias,Denmark
208,2,1,405,28,149,10216666,1.36,1943,1947,Chronic myeloid leukaemias,Denmark
208,2,1,406,56,0,10216666,0,1943,1947,Other and unspecified myeloid leukaemia,Denmark
208,2,1,407,38,65,10216666,0.6,1943,1947,"Leukaemia, cell unspecified",Denmark
208,2,1,410,26,202,10216666,1.7,1943,1947,Other specified cancers,Denmark
208,2,1,420,5,1420,10216666,11.53,1943,1947,Other and ill-defined cancers,Denmark
208,2,1,430,9,894,10216666,8.03,1943,1947,Malignant haematopoietic diseases,Denmark
208,2,1,510,17,354,10216666,2.94,1943,1947,"Lip, oral cavity and pharynx",Denmark
208,2,1,520,3,3376,10216666,27.28,1943,1947,Colorectal,Denmark
208,2,10,10,52,42,14526691,0.11,2016,2020,Lip,Denmark
208,2,10,20,28,685,14526691,2.18,2016,2020,Oral Cavity,Denmark
208,2,10,30,43,164,14526691,0.67,2016,2020,Salivary glands,Denmark
208,2,10,40,29,581,14526691,2.17,2016,2020,Oropharynx,Denmark
208,2,10,41,50,39,14526691,0.18,2016,2020,Nasopharynx,Denmark
208,2,10,50,49,81,14526691,0.27,2016,2020,Hypopharynx,Denmark
208,2,10,60,26,781,14526691,2.24,2016,2020,Oesophagus,Denmark
208,2,10,70,23,1093,14526691,3.25,2016,2020,Stomach,Denmark
208,2,10,80,36,519,14526691,1.69,2016,2020,Small intestine,Denmark
208,2,10,110,27,755,14526691,2.21,2016,2020,Liver,Denmark
208,2,10,120,33,651,14526691,1.78,2016,2020,Gallbladder,Denmark
208,2,10,130,16,2594,14526691,6.99,2016,2020,Pancreas,Denmark
208,2,10,140,44,154,14526691,0.59,2016,2020,"Nasal Cavity, middle ear and sinuses",Denmark
208,2,10,150,42,234,14526691,0.78,2016,2020,Larynx,Denmark
208,2,10,160,2,12455,14526691,36.3,2016,2020,Lung,Denmark
208,2,10,170,48,111,14526691,0.29,2016,2020,Pleura,Denmark
208,2,10,180,1,24122,14526691,90.81,2016,2020,Breast,Denmark
208,2,10,190,12,1709,14526691,8.91,2016,2020,Cervix uteri,Denmark
208,2,10,200,9,4053,14526691,12.91,2016,2020,Corpus uteri,Denmark
208,2,10,210,53,35,14526691,0.11,2016,2020,"Uterus, other",Denmark
208,2,10,220,11,2787,14526691,9.54,2016,2020,Ovary and tubes,Denmark
208,2,10,227,32,597,14526691,1.83,2016,2020,Vulva,Denmark
208,2,10,228,45,138,14526691,0.39,2016,2020,Vagina,Denmark
208,2,10,229,55,34,14526691,0.08,2016,2020,Other female genital organs,Denmark
208,2,10,230,25,769,14526691,2.31,2016,2020,"Vulva, vagina and other female genital organs",Denmark
208,2,10,270,19,1602,14526691,5.5,2016,2020,Kidney,Denmark
208,2,10,280,13,3046,14526691,8.5,2016,2020,Bladder and urinary tract,Denmark
208,2,10,290,5,6901,14526691,29.62,2016,2020,Melanoma of skin,Denmark
208,2,10,300,8,7804,14526691,17.94,2016,2020,"Skin, non-melanoma",Denmark
208,2,10,310,39,227,14526691,1.03,2016,2020,Eye,Denmark
208,2,10,315,56,4,14526691,0.02,2016,2020,Endocrine tumors of brain and CNS,Denmark
208,2,10,316,21,1044,14526691,4.24,2016,2020,Meningiomas,Denmark
208,2,10,320,7,5413,14526691,22.5,2016,2020,Brain and CNS excluding endocrine tumors,Denmark
208,2,10,321,6,5417,14526691,22.51,2016,2020,Brain and CNS including endocrine tumors,Denmark
208,2,10,330,14,1575,14526691,8.04,2016,2020,Thyroid,Denmark
208,2,10,340,40,166,14526691,1.03,2016,2020,Bone,Denmark
208,2,10,350,31,487,14526691,2,2016,2020,Soft tissues,Denmark
208,2,10,360,10,3156,14526691,10.02,2016,2020,Non Hodgkin lymphomas,Denmark
208,2,10,370,30,340,14526691,2.12,2016,2020,Hodgkin lymphomas,Denmark
208,2,10,380,22,1209,14526691,3.4,2016,2020,Multiple myelomas,Denmark
208,2,10,390,37,609,14526691,1.67,2016,2020,Myelodysplastic syndromes,Denmark
208,2,10,392,17,1752,14526691,5.64,2016,2020,Myeloproliferative diseases,Denmark
208,2,10,394,51,49,14526691,0.14,2016,2020,Other hematopoietic diseases,Denmark
208,2,10,400,15,2013,14526691,7.32,2016,2020,Leukaemias,Denmark
208,2,10,401,38,129,14526691,1.29,2016,2020,Acute lymphatic leukaemias,Denmark
208,2,10,402,24,896,14526691,2.51,2016,2020,Chronic lymphatic leukaemias,Denmark
208,2,10,403,46,107,14526691,0.33,2016,2020,Other and unspecified lymphatic leukaemias,Denmark
208,2,10,404,34,442,14526691,1.74,2016,2020,Acute myeloid leukaemias,Denmark
208,2,10,405,41,275,14526691,0.92,2016,2020,Chronic myeloid leukaemias,Denmark
208,2,10,406,47,100,14526691,0.3,2016,2020,Other and unspecified myeloid leukaemia,Denmark
208,2,10,407,54,21,14526691,0.11,2016,2020,"Leukaemia, cell unspecified",Denmark
208,2,10,410,35,422,14526691,1.74,2016,2020,Other specified cancers,Denmark
208,2,10,420,20,1632,14526691,4.48,2016,2020,Other and ill-defined cancers,Denmark
208,2,10,430,4,9085,14526691,30.19,2016,2020,Malignant haematopoietic diseases,Denmark
208,2,10,510,18,1592,14526691,5.58,2016,2020,"Lip, oral cavity and pharynx",Denmark
208,2,10,520,3,11240,14526691,31.88,2016,2020,Colorectal,Denmark
246,1,1,10,9,717,10151751.5,7.92,1953,1957,Lip,Finland
246,1,1,20,24,157,10151751.5,1.8,1953,1957,Oral Cavity,Finland
246,1,1,30,30,81,10151751.5,0.91,1953,1957,Salivary glands,Finland
246,1,1,40,36,54,10151751.5,0.65,1953,1957,Oropharynx,Finland
246,1,1,41,41,19,10151751.5,0.21,1953,1957,Nasopharynx,Finland
246,1,1,50,39,43,10151751.5,0.48,1953,1957,Hypopharynx,Finland
246,1,1,60,8,769,10151751.5,9.05,1953,1957,Oesophagus,Finland
246,1,1,70,1,5486,10151751.5,62.97,1953,1957,Stomach,Finland
246,1,1,80,38,56,10151751.5,0.61,1953,1957,Small intestine,Finland
246,1,1,110,25,149,10151751.5,1.7,1953,1957,Liver,Finland
246,1,1,120,37,55,10151751.5,0.65,1953,1957,Gallbladder,Finland
246,1,1,130,10,533,10151751.5,5.96,1953,1957,Pancreas,Finland
246,1,1,140,29,94,10151751.5,1.01,1953,1957,"Nasal Cavity, middle ear and sinuses",Finland
246,1,1,150,13,509,10151751.5,5.41,1953,1957,Larynx,Finland
246,1,1,160,2,4717,10151751.5,52.34,1953,1957,Lung,Finland
246,1,1,170,43,5,10151751.5,0.05,1953,1957,Pleura,Finland
246,1,1,180,42,16,10151751.5,0.2,1953,1957,Breast,Finland
246,1,1,240,3,1113,10151751.5,14.05,1953,1957,Prostate,Finland
246,1,1,250,32,80,10151751.5,0.8,1953,1957,Testis,Finland
246,1,1,260,35,61,10151751.5,0.66,1953,1957,Penis and other male genital organs,Finland
246,1,1,270,18,316,10151751.5,3.41,1953,1957,Kidney,Finland
246,1,1,280,12,496,10151751.5,5.92,1953,1957,Bladder and urinary tract,Finland
246,1,1,290,27,141,10151751.5,1.47,1953,1957,Melanoma of skin,Finland
246,1,1,300,17,323,10151751.5,3.73,1953,1957,"Skin, non-melanoma",Finland
246,1,1,310,34,68,10151751.5,0.73,1953,1957,Eye,Finland
246,1,1,315,46,2,10151751.5,0.02,1953,1957,Endocrine tumors of brain and CNS,Finland
246,1,1,316,40,30,10151751.5,0.3,1953,1957,Meningiomas,Finland
246,1,1,320,15,485,10151751.5,4.82,1953,1957,Brain and CNS excluding endocrine tumors,Finland
246,1,1,321,14,487,10151751.5,4.84,1953,1957,Brain and CNS including endocrine tumors,Finland
246,1,1,330,31,80,10151751.5,0.85,1953,1957,Thyroid,Finland
246,1,1,340,21,193,10151751.5,2.07,1953,1957,Bone,Finland
246,1,1,350,26,160,10151751.5,1.64,1953,1957,Soft tissues,Finland
246,1,1,360,16,362,10151751.5,3.94,1953,1957,Non Hodgkin lymphomas,Finland
246,1,1,370,19,263,10151751.5,2.61,1953,1957,Hodgkin lymphomas,Finland
246,1,1,380,33,69,10151751.5,0.74,1953,1957,Multiple myelomas,Finland
246,1,1,390,49,0,10151751.5,0,1953,1957,Myelodysplastic syndromes,Finland
246,1,1,392,45,3,10151751.5,0.03,1953,1957,Myeloproliferative diseases,Finland
246,1,1,394,47,1,10151751.5,0.01,1953,1957,Other hematopoietic diseases,Finland
246,1,1,400,11,576,10151751.5,5.94,1953,1957,Leukaemias,Finland
246,1,1,401,50,0,10151751.5,0,1953,1957,Acute lymphatic leukaemias,Finland
246,1,1,402,23,170,10151751.5,1.81,1953,1957,Chronic lymphatic leukaemias,Finland
246,1,1,403,44,5,10151751.5,0.05,1953,1957,Other and unspecified lymphatic leukaemias,Finland
246,1,1,404,48,1,10151751.5,0.01,1953,1957,Acute myeloid leukaemias,Finland
246,1,1,405,20,216,10151751.5,2.17,1953,1957,Chronic myeloid leukaemias,Finland
246,1,1,406,51,0,10151751.5,0,1953,1957,Other and unspecified myeloid leukaemia,Finland
246,1,1,407,22,184,10151751.5,1.89,1953,1957,"Leukaemia, cell unspecified",Finland
246,1,1,410,28,125,10151751.5,1.36,1953,1957,Other specified cancers,Finland
246,1,1,420,6,962,10151751.5,11.29,1953,1957,Other and ill-defined cancers,Finland
246,1,1,430,4,1274,10151751.5,13.27,1953,1957,Malignant haematopoietic diseases,Finland
246,1,1,510,5,1071,10151751.5,11.97,1953,1957,"Lip, oral cavity and pharynx",Finland
246,1,1,520,7,859,10151751.5,10.06,1953,1957,Colorectal,Finland
246,1,10,10,47,141,13600659,0.36,2016,2020,Lip,Finland
246,1,10,20,20,916,13600659,3.48,2016,2020,Oral Cavity,Finland
246,1,10,30,40,200,13600659,0.75,2016,2020,Salivary glands,Finland
246,1,10,40,26,722,13600659,2.94,2016,2020,Oropharynx,Finland
246,1,10,41,48,63,13600659,0.29,2016,2020,Nasopharynx,Finland
246,1,10,50,44,165,13600659,0.58,2016,2020,Hypopharynx,Finland
246,1,10,60,19,1293,13600659,4.38,2016,2020,Oesophagus,Finland
246,1,10,70,17,1815,13600659,5.78,2016,2020,Stomach,Finland
246,1,10,80,32,510,13600659,1.75,2016,2020,Small intestine,Finland
246,1,10,110,15,1910,13600659,5.92,2016,2020,Liver,Finland
246,1,10,120,30,716,13600659,2.23,2016,2020,Gallbladder,Finland
246,1,10,130,10,3268,13600659,10.26,2016,2020,Pancreas,Finland
246,1,10,140,43,159,13600659,0.61,2016,2020,"Nasal Cavity, middle ear and sinuses",Finland
246,1,10,150,31,558,13600659,1.88,2016,2020,Larynx,Finland
246,1,10,160,4,8891,13600659,26.65,2016,2020,Lung,Finland
246,1,10,170,36,360,13600659,0.95,2016,2020,Pleura,Finland
246,1,10,180,45,157,13600659,0.55,2016,2020,Breast,Finland
246,1,10,240,1,25990,13600659,79.23,2016,2020,Prostate,Finland
246,1,10,250,16,801,13600659,5.88,2016,2020,Testis,Finland
246,1,10,260,37,217,13600659,0.84,2016,2020,Penis and other male genital organs,Finland
246,1,10,270,9,3070,13600659,11.13,2016,2020,Kidney,Finland
246,1,10,280,6,5253,13600659,15.39,2016,2020,Bladder and urinary tract,Finland
246,1,10,290,5,4612,13600659,17.32,2016,2020,Melanoma of skin,Finland
246,1,10,300,7,5146,13600659,13.09,2016,2020,"Skin, non-melanoma",Finland
246,1,10,310,42,141,13600659,0.64,2016,2020,Eye,Finland
246,1,10,315,51,8,13600659,0.08,2016,2020,Endocrine tumors of brain and CNS,Finland
246,1,10,316,29,567,13600659,2.25,2016,2020,Meningiomas,Finland
246,1,10,320,12,2100,13600659,10.16,2016,2020,Brain and CNS excluding endocrine tumors,Finland
246,1,10,321,11,2108,13600659,10.24,2016,2020,Brain and CNS including endocrine tumors,Finland
246,1,10,330,21,760,13600659,3.46,2016,2020,Thyroid,Finland
246,1,10,340,39,132,13600659,0.76,2016,2020,Bone,Finland
246,1,10,350,27,626,13600659,2.71,2016,2020,Soft tissues,Finland
246,1,10,360,8,3506,13600659,12.44,2016,2020,Non Hodgkin lymphomas,Finland
246,1,10,370,24,491,13600659,3.1,2016,2020,Hodgkin lymphomas,Finland
246,1,10,380,23,1048,13600659,3.34,2016,2020,Multiple myelomas,Finland
246,1,10,390,35,374,13600659,1,2016,2020,Myelodysplastic syndromes,Finland
246,1,10,392,22,897,13600659,3.44,2016,2020,Myeloproliferative diseases,Finland
246,1,10,394,38,226,13600659,0.81,2016,2020,Other hematopoietic diseases,Finland
246,1,10,400,13,2044,13600659,8.76,2016,2020,Leukaemias,Finland
246,1,10,401,28,236,13600659,2.55,2016,2020,Acute lymphatic leukaemias,Finland
246,1,10,402,25,976,13600659,3.1,2016,2020,Chronic lymphatic leukaemias,Finland
246,1,10,403,46,100,13600659,0.37,2016,2020,Other and unspecified lymphatic leukaemias,Finland
246,1,10,404,34,432,13600659,1.68,2016,2020,Acute myeloid leukaemias,Finland
246,1,10,405,41,192,13600659,0.71,2016,2020,Chronic myeloid leukaemias,Finland
246,1,10,406,50,33,13600659,0.11,2016,2020,Other and unspecified myeloid leukaemia,Finland
246,1,10,407,49,62,13600659,0.19,2016,2020,"Leukaemia, cell unspecified",Finland
246,1,10,410,33,396,13600659,1.74,2016,2020,Other specified cancers,Finland
246,1,10,420,18,1563,13600659,4.56,2016,2020,Other and ill-defined cancers,Finland
246,1,10,430,2,8573,13600659,32.85,2016,2020,Malignant haematopoietic diseases,Finland
246,1,10,510,14,2207,13600659,8.4,2016,2020,"Lip, oral cavity and pharynx",Finland
246,1,10,520,3,9400,13600659,30.12,2016,2020,Colorectal,Finland
246,2,1,10,43,56,11015160.5,0.44,1953,1957,Lip,Finland
246,2,1,20,32,128,11015160.5,1.02,1953,1957,Oral Cavity,Finland
246,2,1,30,39,74,11015160.5,0.6,1953,1957,Salivary glands,Finland
246,2,1,40,46,25,11015160.5,0.19,1953,1957,Oropharynx,Finland
246,2,1,41,47,17,11015160.5,0.13,1953,1957,Nasopharynx,Finland
246,2,1,50,41,59,11015160.5,0.48,1953,1957,Hypopharynx,Finland
246,2,1,60,9,799,11015160.5,6.27,1953,1957,Oesophagus,Finland
246,2,1,70,1,4694,11015160.5,36.5,1953,1957,Stomach,Finland
246,2,1,80,37,90,11015160.5,0.7,1953,1957,Small intestine,Finland
246,2,1,110,31,140,11015160.5,1.05,1953,1957,Liver,Finland
246,2,1,120,30,138,11015160.5,1.09,1953,1957,Gallbladder,Finland
246,2,1,130,14,457,11015160.5,3.64,1953,1957,Pancreas,Finland
246,2,1,140,33,104,11015160.5,0.84,1953,1957,"Nasal Cavity, middle ear and sinuses",Finland
246,2,1,150,44,40,11015160.5,0.32,1953,1957,Larynx,Finland
246,2,1,160,13,482,11015160.5,3.75,1953,1957,Lung,Finland
246,2,1,170,48,6,11015160.5,0.05,1953,1957,Pleura,Finland
246,2,1,180,2,3216,11015160.5,25.85,1953,1957,Breast,Finland
246,2,1,190,3,1730,11015160.5,13.96,1953,1957,Cervix uteri,Finland
246,2,1,200,6,1064,11015160.5,8.58,1953,1957,Corpus uteri,Finland
246,2,1,210,29,146,11015160.5,1.17,1953,1957,"Uterus, other",Finland
246,2,1,220,8,797,11015160.5,6.44,1953,1957,Ovary and tubes,Finland
246,2,1,227,25,182,11015160.5,1.4,1953,1957,Vulva,Finland
246,2,1,228,45,38,11015160.5,0.31,1953,1957,Vagina,Finland
246,2,1,229,42,58,11015160.5,0.45,1953,1957,Other female genital organs,Finland
246,2,1,230,18,278,11015160.5,2.16,1953,1957,"Vulva, vagina and other female genital organs",Finland
246,2,1,270,17,271,11015160.5,2.24,1953,1957,Kidney,Finland
246,2,1,280,27,158,11015160.5,1.26,1953,1957,Bladder and urinary tract,Finland
246,2,1,290,22,199,11015160.5,1.67,1953,1957,Melanoma of skin,Finland
246,2,1,300,15,361,11015160.5,2.93,1953,1957,"Skin, non-melanoma",Finland
246,2,1,310,38,74,11015160.5,0.64,1953,1957,Eye,Finland
246,2,1,315,49,3,11015160.5,0.03,1953,1957,Endocrine tumors of brain and CNS,Finland
246,2,1,316,35,95,11015160.5,0.79,1953,1957,Meningiomas,Finland
246,2,1,320,12,445,11015160.5,3.83,1953,1957,Brain and CNS excluding endocrine tumors,Finland
246,2,1,321,11,448,11015160.5,3.86,1953,1957,Brain and CNS including endocrine tumors,Finland
246,2,1,330,20,246,11015160.5,1.96,1953,1957,Thyroid,Finland
246,2,1,340,23,170,11015160.5,1.45,1953,1957,Bone,Finland
246,2,1,350,26,158,11015160.5,1.34,1953,1957,Soft tissues,Finland
246,2,1,360,19,238,11015160.5,1.98,1953,1957,Non Hodgkin lymphomas,Finland
246,2,1,370,28,136,11015160.5,1.18,1953,1957,Hodgkin lymphomas,Finland
246,2,1,380,36,93,11015160.5,0.74,1953,1957,Multiple myelomas,Finland
246,2,1,390,54,0,11015160.5,0,1953,1957,Myelodysplastic syndromes,Finland
246,2,1,392,50,2,11015160.5,0.02,1953,1957,Myeloproliferative diseases,Finland
246,2,1,394,55,0,11015160.5,0,1953,1957,Other hematopoietic diseases,Finland
246,2,1,400,10,482,11015160.5,4.1,1953,1957,Leukaemias,Finland
246,2,1,401,52,1,11015160.5,0.01,1953,1957,Acute lymphatic leukaemias,Finland
246,2,1,402,34,100,11015160.5,0.81,1953,1957,Chronic lymphatic leukaemias,Finland
246,2,1,403,53,1,11015160.5,0.01,1953,1957,Other and unspecified lymphatic leukaemias,Finland
246,2,1,404,51,2,11015160.5,0.02,1953,1957,Acute myeloid leukaemias,Finland
246,2,1,405,21,214,11015160.5,1.8,1953,1957,Chronic myeloid leukaemias,Finland
246,2,1,406,56,0,11015160.5,0,1953,1957,Other and unspecified myeloid leukaemia,Finland
246,2,1,407,24,164,11015160.5,1.45,1953,1957,"Leukaemia, cell unspecified",Finland
246,2,1,410,40,60,11015160.5,0.52,1953,1957,Other specified cancers,Finland
246,2,1,420,4,1273,11015160.5,9.88,1953,1957,Other and ill-defined cancers,Finland
246,2,1,430,7,951,11015160.5,8.01,1953,1957,Malignant haematopoietic diseases,Finland
246,2,1,510,16,359,11015160.5,2.86,1953,1957,"Lip, oral cavity and pharynx",Finland
246,2,1,520,5,1226,11015160.5,9.63,1953,1957,Colorectal,Finland
246,2,10,10,49,90,13969529.5,0.17,2016,2020,Lip,Finland
246,2,10,20,27,723,13969529.5,2.18,2016,2020,Oral Cavity,Finland
246,2,10,30,41,168,13969529.5,0.63,2016,2020,Salivary glands,Finland
246,2,10,40,37,295,13969529.5,1.13,2016,2020,Oropharynx,Finland
246,2,10,41,52,25,13969529.5,0.1,2016,2020,Nasopharynx,Finland
246,2,10,50,54,26,13969529.5,0.09,2016,2020,Hypopharynx,Finland
246,2,10,60,36,524,13969529.5,1.3,2016,2020,Oesophagus,Finland
246,2,10,70,20,1282,13969529.5,3.57,2016,2020,Stomach,Finland
246,2,10,80,32,450,13969529.5,1.42,2016,2020,Small intestine,Finland
246,2,10,110,26,863,13969529.5,2.19,2016,2020,Liver,Finland
246,2,10,120,29,942,13969529.5,2.17,2016,2020,Gallbladder,Finland
246,2,10,130,13,3319,13969529.5,7.84,2016,2020,Pancreas,Finland
246,2,10,140,45,110,13969529.5,0.37,2016,2020,"Nasal Cavity, middle ear and sinuses",Finland
246,2,10,150,47,95,13969529.5,0.29,2016,2020,Larynx,Finland
246,2,10,160,5,5503,13969529.5,14.45,2016,2020,Lung,Finland
246,2,10,170,48,115,13969529.5,0.28,2016,2020,Pleura,Finland
246,2,10,180,1,24892,13969529.5,92.14,2016,2020,Breast,Finland
246,2,10,190,17,863,13969529.5,4.6,2016,2020,Cervix uteri,Finland
246,2,10,200,6,4483,13969529.5,13.35,2016,2020,Corpus uteri,Finland
246,2,10,210,51,50,13969529.5,0.12,2016,2020,"Uterus, other",Finland
246,2,10,220,11,2657,13969529.5,9.04,2016,2020,Ovary and tubes,Finland
246,2,10,227,34,547,13969529.5,1.41,2016,2020,Vulva,Finland
246,2,10,228,46,124,13969529.5,0.36,2016,2020,Vagina,Finland
246,2,10,229,38,315,13969529.5,0.69,2016,2020,Other female genital organs,Finland
246,2,10,230,24,986,13969529.5,2.46,2016,2020,"Vulva, vagina and other female genital organs",Finland
246,2,10,270,15,1945,13969529.5,5.82,2016,2020,Kidney,Finland
246,2,10,280,19,1586,13969529.5,3.69,2016,2020,Bladder and urinary tract,Finland
246,2,10,290,4,4153,13969529.5,17.05,2016,2020,Melanoma of skin,Finland
246,2,10,300,12,4313,13969529.5,7.86,2016,2020,"Skin, non-melanoma",Finland
246,2,10,310,43,126,13969529.5,0.59,2016,2020,Eye,Finland
246,2,10,315,55,6,13969529.5,0.06,2016,2020,Endocrine tumors of brain and CNS,Finland
246,2,10,316,14,1537,13969529.5,6.06,2016,2020,Meningiomas,Finland
246,2,10,320,8,2893,13969529.5,12.47,2016,2020,Brain and CNS excluding endocrine tumors,Finland
246,2,10,321,7,2899,13969529.5,12.53,2016,2020,Brain and CNS including endocrine tumors,Finland
246,2,10,330,9,1845,13969529.5,9.45,2016,2020,Thyroid,Finland
246,2,10,340,39,122,13969529.5,0.69,2016,2020,Bone,Finland
246,2,10,350,31,435,13969529.5,1.59,2016,2020,Soft tissues,Finland
246,2,10,360,10,3019,13969529.5,9.07,2016,2020,Non Hodgkin lymphomas,Finland
246,2,10,370,23,354,13969529.5,2.5,2016,2020,Hodgkin lymphomas,Finland
246,2,10,380,25,936,13969529.5,2.36,2016,2020,Multiple myelomas,Finland
246,2,10,390,42,282,13969529.5,0.6,2016,2020,Myelodysplastic syndromes,Finland
246,2,10,392,22,1000,13969529.5,3.21,2016,2020,Myeloproliferative diseases,Finland
246,2,10,394,40,213,13969529.5,0.64,2016,2020,Other hematopoietic diseases,Finland
246,2,10,400,16,1385,13969529.5,5.47,2016,2020,Leukaemias,Finland
246,2,10,401,30,166,13969529.5,1.85,2016,2020,Acute lymphatic leukaemias,Finland
246,2,10,402,33,566,13969529.5,1.42,2016,2020,Chronic lymphatic leukaemias,Finland
246,2,10,403,50,46,13969529.5,0.13,2016,2020,Other and unspecified lymphatic leukaemias,Finland
246,2,10,404,35,388,13969529.5,1.36,2016,2020,Acute myeloid leukaemias,Finland
246,2,10,405,44,142,13969529.5,0.52,2016,2020,Chronic myeloid leukaemias,Finland
246,2,10,406,56,22,13969529.5,0.05,2016,2020,Other and unspecified myeloid leukaemia,Finland
246,2,10,407,53,42,13969529.5,0.1,2016,2020,"Leukaemia, cell unspecified",Finland
246,2,10,410,28,571,13969529.5,2.18,2016,2020,Other specified cancers,Finland
246,2,10,420,21,1676,13969529.5,3.31,2016,2020,Other and ill-defined cancers,Finland
246,2,10,430,2,7176,13969529.5,23.8,2016,2020,Malignant haematopoietic diseases,Finland
246,2,10,510,18,1327,13969529.5,4.29,2016,2020,"Lip, oral cavity and pharynx",Finland
246,2,10,520,3,8275,13969529.5,22.23,2016,2020,Colorectal,Finland
304,1,1,10,33,0,135207,0,1977,1981,Lip,Greenland
304,1,1,20,10,4,135207,5.88,1977,1981,Oral Cavity,Greenland
304,1,1,30,14,3,135207,3.54,1977,1981,Salivary glands,Greenland
304,1,1,40,21,2,135207,1.89,1977,1981,Oropharynx,Greenland
304,1,1,41,11,7,135207,5.74,1977,1981,Nasopharynx,Greenland
304,1,1,50,27,1,135207,0.99,1977,1981,Hypopharynx,Greenland
304,1,1,60,5,10,135207,15.72,1977,1981,Oesophagus,Greenland
304,1,1,70,8,7,135207,7.58,1977,1981,Stomach,Greenland
304,1,1,80,34,0,135207,0,1977,1981,Small intestine,Greenland
304,1,1,110,23,1,135207,1.23,1977,1981,Liver,Greenland
304,1,1,120,35,0,135207,0,1977,1981,Gallbladder,Greenland
304,1,1,130,6,7,135207,11.64,1977,1981,Pancreas,Greenland
304,1,1,140,36,0,135207,0,1977,1981,"Nasal Cavity, middle ear and sinuses",Greenland
304,1,1,150,28,1,135207,0.99,1977,1981,Larynx,Greenland
304,1,1,160,1,44,135207,56.86,1977,1981,Lung,Greenland
304,1,1,170,37,0,135207,0,1977,1981,Pleura,Greenland
304,1,1,180,19,1,135207,2.03,1977,1981,Breast,Greenland
304,1,1,240,13,2,135207,3.66,1977,1981,Prostate,Greenland
304,1,1,250,12,6,135207,4.2,1977,1981,Testis,Greenland
304,1,1,260,20,1,135207,2.03,1977,1981,Penis and other male genital organs,Greenland
304,1,1,270,17,2,135207,2.74,1977,1981,Kidney,Greenland
304,1,1,280,7,7,135207,9.56,1977,1981,Bladder and urinary tract,Greenland
304,1,1,290,22,2,135207,1.63,1977,1981,Melanoma of skin,Greenland
304,1,1,300,15,3,135207,3.46,1977,1981,"Skin, non-melanoma",Greenland
304,1,1,310,24,1,135207,1.23,1977,1981,Eye,Greenland
304,1,1,315,38,0,135207,0,1977,1981,Endocrine tumors of brain and CNS,Greenland
304,1,1,316,39,0,135207,0,1977,1981,Meningiomas,Greenland
304,1,1,320,29,1,135207,0.6,1977,1981,Brain and CNS excluding endocrine tumors,Greenland
304,1,1,321,30,1,135207,0.6,1977,1981,Brain and CNS including endocrine tumors,Greenland
304,1,1,330,40,0,135207,0,1977,1981,Thyroid,Greenland
304,1,1,340,32,1,135207,0.52,1977,1981,Bone,Greenland
304,1,1,350,31,1,135207,0.6,1977,1981,Soft tissues,Greenland
304,1,1,360,18,3,135207,2.57,1977,1981,Non Hodgkin lymphomas,Greenland
304,1,1,370,25,1,135207,1.11,1977,1981,Hodgkin lymphomas,Greenland
304,1,1,380,16,2,135207,3.06,1977,1981,Multiple myelomas,Greenland
304,1,1,390,41,0,135207,0,1977,1981,Myelodysplastic syndromes,Greenland
304,1,1,392,42,0,135207,0,1977,1981,Myeloproliferative diseases,Greenland
304,1,1,394,43,0,135207,0,1977,1981,Other hematopoietic diseases,Greenland
304,1,1,400,44,0,135207,0,1977,1981,Leukaemias,Greenland
304,1,1,401,45,0,135207,0,1977,1981,Acute lymphatic leukaemias,Greenland
304,1,1,402,46,0,135207,0,1977,1981,Chronic lymphatic leukaemias,Greenland
304,1,1,403,47,0,135207,0,1977,1981,Other and unspecified lymphatic leukaemias,Greenland
304,1,1,404,48,0,135207,0,1977,1981,Acute myeloid leukaemias,Greenland
304,1,1,405,49,0,135207,0,1977,1981,Chronic myeloid leukaemias,Greenland
304,1,1,406,50,0,135207,0,1977,1981,Other and unspecified myeloid leukaemia,Greenland
304,1,1,407,51,0,135207,0,1977,1981,"Leukaemia, cell unspecified",Greenland
304,1,1,410,26,2,135207,1.07,1977,1981,Other specified cancers,Greenland
304,1,1,420,2,21,135207,31.68,1977,1981,Other and ill-defined cancers,Greenland
304,1,1,430,9,6,135207,6.73,1977,1981,Malignant haematopoietic diseases,Greenland
304,1,1,510,4,17,135207,18.04,1977,1981,"Lip, oral cavity and pharynx",Greenland
304,1,1,520,3,18,135207,24.54,1977,1981,Colorectal,Greenland
304,1,10,10,44,0,147732,0,2016,2020,Lip,Greenland
304,1,10,20,20,7,147732,4.41,2016,2020,Oral Cavity,Greenland
304,1,10,30,41,2,147732,0.71,2016,2020,Salivary glands,Greenland
304,1,10,40,17,11,147732,5.35,2016,2020,Oropharynx,Greenland
304,1,10,41,12,17,147732,7.89,2016,2020,Nasopharynx,Greenland
304,1,10,50,21,9,147732,4.2,2016,2020,Hypopharynx,Greenland
304,1,10,60,7,33,147732,17.66,2016,2020,Oesophagus,Greenland
304,1,10,70,6,37,147732,18.08,2016,2020,Stomach,Greenland
304,1,10,80,27,5,147732,2.28,2016,2020,Small intestine,Greenland
304,1,10,110,10,17,147732,8.66,2016,2020,Liver,Greenland
304,1,10,120,30,4,147732,2.1,2016,2020,Gallbladder,Greenland
304,1,10,130,11,18,147732,8.15,2016,2020,Pancreas,Greenland
304,1,10,140,38,2,147732,0.81,2016,2020,"Nasal Cavity, middle ear and sinuses",Greenland
304,1,10,150,29,4,147732,2.12,2016,2020,Larynx,Greenland
304,1,10,160,2,139,147732,67.81,2016,2020,Lung,Greenland
304,1,10,170,33,4,147732,1.75,2016,2020,Pleura,Greenland
304,1,10,180,45,0,147732,0,2016,2020,Breast,Greenland
304,1,10,240,5,40,147732,19.28,2016,2020,Prostate,Greenland
304,1,10,250,15,10,147732,6.13,2016,2020,Testis,Greenland
304,1,10,260,36,2,147732,0.9,2016,2020,Penis and other male genital organs,Greenland
304,1,10,270,8,28,147732,12.55,2016,2020,Kidney,Greenland
304,1,10,280,9,17,147732,9.82,2016,2020,Bladder and urinary tract,Greenland
304,1,10,290,26,5,147732,2.29,2016,2020,Melanoma of skin,Greenland
304,1,10,300,31,4,147732,2.04,2016,2020,"Skin, non-melanoma",Greenland
304,1,10,310,22,5,147732,3.7,2016,2020,Eye,Greenland
304,1,10,315,46,0,147732,0,2016,2020,Endocrine tumors of brain and CNS,Greenland
304,1,10,316,40,2,147732,0.75,2016,2020,Meningiomas,Greenland
304,1,10,320,18,11,147732,5.11,2016,2020,Brain and CNS excluding endocrine tumors,Greenland
304,1,10,321,19,11,147732,5.11,2016,2020,Brain and CNS including endocrine tumors,Greenland
304,1,10,330,39,2,147732,0.78,2016,2020,Thyroid,Greenland
304,1,10,340,47,0,147732,0,2016,2020,Bone,Greenland
304,1,10,350,34,2,147732,1.25,2016,2020,Soft tissues,Greenland
304,1,10,360,13,18,147732,7.85,2016,2020,Non Hodgkin lymphomas,Greenland
304,1,10,370,25,5,147732,2.7,2016,2020,Hodgkin lymphomas,Greenland
304,1,10,380,24,6,147732,2.78,2016,2020,Multiple myelomas,Greenland
304,1,10,390,43,1,147732,0.48,2016,2020,Myelodysplastic syndromes,Greenland
304,1,10,392,28,5,147732,2.21,2016,2020,Myeloproliferative diseases,Greenland
304,1,10,394,48,0,147732,0,2016,2020,Other hematopoietic diseases,Greenland
304,1,10,400,16,8,147732,5.49,2016,2020,Leukaemias,Greenland
304,1,10,401,23,3,147732,3.05,2016,2020,Acute lymphatic leukaemias,Greenland
304,1,10,402,35,2,147732,1.01,2016,2020,Chronic lymphatic leukaemias,Greenland
304,1,10,403,49,0,147732,0,2016,2020,Other and unspecified lymphatic leukaemias,Greenland
304,1,10,404,37,2,147732,0.9,2016,2020,Acute myeloid leukaemias,Greenland
304,1,10,405,42,1,147732,0.53,2016,2020,Chronic myeloid leukaemias,Greenland
304,1,10,406,50,0,147732,0,2016,2020,Other and unspecified myeloid leukaemia,Greenland
304,1,10,407,51,0,147732,0,2016,2020,"Leukaemia, cell unspecified",Greenland
304,1,10,410,32,4,147732,1.78,2016,2020,Other specified cancers,Greenland
304,1,10,420,14,12,147732,6.46,2016,2020,Other and ill-defined cancers,Greenland
304,1,10,430,4,43,147732,21.52,2016,2020,Malignant haematopoietic diseases,Greenland
304,1,10,510,3,46,147732,22.56,2016,2020,"Lip, oral cavity and pharynx",Greenland
304,1,10,520,1,152,147732,74.52,2016,2020,Colorectal,Greenland
304,2,1,10,35,0,114271,0,1977,1981,Lip,Greenland
304,2,1,20,36,0,114271,0,1977,1981,Oral Cavity,Greenland
304,2,1,30,17,4,114271,4.86,1977,1981,Salivary glands,Greenland
304,2,1,40,37,0,114271,0,1977,1981,Oropharynx,Greenland
304,2,1,41,10,6,114271,7.06,1977,1981,Nasopharynx,Greenland
304,2,1,50,38,0,114271,0,1977,1981,Hypopharynx,Greenland
304,2,1,60,8,9,114271,11.72,1977,1981,Oesophagus,Greenland
304,2,1,70,14,6,114271,6.55,1977,1981,Stomach,Greenland
304,2,1,80,39,0,114271,0,1977,1981,Small intestine,Greenland
304,2,1,110,40,0,114271,0,1977,1981,Liver,Greenland
304,2,1,120,19,3,114271,4.24,1977,1981,Gallbladder,Greenland
304,2,1,130,9,6,114271,7.49,1977,1981,Pancreas,Greenland
304,2,1,140,26,1,114271,1.3,1977,1981,"Nasal Cavity, middle ear and sinuses",Greenland
304,2,1,150,41,0,114271,0,1977,1981,Larynx,Greenland
304,2,1,160,4,18,114271,24.3,1977,1981,Lung,Greenland
304,2,1,170,42,0,114271,0,1977,1981,Pleura,Greenland
304,2,1,180,2,29,114271,30.57,1977,1981,Breast,Greenland
304,2,1,190,1,47,114271,47.36,1977,1981,Cervix uteri,Greenland
304,2,1,200,13,5,114271,6.71,1977,1981,Corpus uteri,Greenland
304,2,1,210,25,1,114271,1.52,1977,1981,"Uterus, other",Greenland
304,2,1,220,6,8,114271,12.1,1977,1981,Ovary and tubes,Greenland
304,2,1,227,32,1,114271,0.73,1977,1981,Vulva,Greenland
304,2,1,228,43,0,114271,0,1977,1981,Vagina,Greenland
304,2,1,229,44,0,114271,0,1977,1981,Other female genital organs,Greenland
304,2,1,230,33,1,114271,0.73,1977,1981,"Vulva, vagina and other female genital organs",Greenland
304,2,1,270,16,5,114271,6.14,1977,1981,Kidney,Greenland
304,2,1,280,20,3,114271,4.18,1977,1981,Bladder and urinary tract,Greenland
304,2,1,290,45,0,114271,0,1977,1981,Melanoma of skin,Greenland
304,2,1,300,46,0,114271,0,1977,1981,"Skin, non-melanoma",Greenland
304,2,1,310,47,0,114271,0,1977,1981,Eye,Greenland
304,2,1,315,48,0,114271,0,1977,1981,Endocrine tumors of brain and CNS,Greenland
304,2,1,316,27,1,114271,1.18,1977,1981,Meningiomas,Greenland
304,2,1,320,11,6,114271,6.91,1977,1981,Brain and CNS excluding endocrine tumors,Greenland
304,2,1,321,12,6,114271,6.91,1977,1981,Brain and CNS including endocrine tumors,Greenland
304,2,1,330,18,4,114271,4.68,1977,1981,Thyroid,Greenland
304,2,1,340,29,1,114271,0.91,1977,1981,Bone,Greenland
304,2,1,350,31,1,114271,0.82,1977,1981,Soft tissues,Greenland
304,2,1,360,23,2,114271,1.91,1977,1981,Non Hodgkin lymphomas,Greenland
304,2,1,370,34,1,114271,0.73,1977,1981,Hodgkin lymphomas,Greenland
304,2,1,380,24,1,114271,1.68,1977,1981,Multiple myelomas,Greenland
304,2,1,390,49,0,114271,0,1977,1981,Myelodysplastic syndromes,Greenland
304,2,1,392,50,0,114271,0,1977,1981,Myeloproliferative diseases,Greenland
304,2,1,394,51,0,114271,0,1977,1981,Other hematopoietic diseases,Greenland
304,2,1,400,22,2,114271,2.09,1977,1981,Leukaemias,Greenland
304,2,1,401,52,0,114271,0,1977,1981,Acute lymphatic leukaemias,Greenland
304,2,1,402,30,1,114271,0.91,1977,1981,Chronic lymphatic leukaemias,Greenland
304,2,1,403,53,0,114271,0,1977,1981,Other and unspecified lymphatic leukaemias,Greenland
304,2,1,404,28,1,114271,1.18,1977,1981,Acute myeloid leukaemias,Greenland
304,2,1,405,54,0,114271,0,1977,1981,Chronic myeloid leukaemias,Greenland
304,2,1,406,55,0,114271,0,1977,1981,Other and unspecified myeloid leukaemia,Greenland
304,2,1,407,56,0,114271,0,1977,1981,"Leukaemia, cell unspecified",Greenland
304,2,1,410,21,3,114271,3.36,1977,1981,Other specified cancers,Greenland
304,2,1,420,3,22,114271,28.59,1977,1981,Other and ill-defined cancers,Greenland
304,2,1,430,15,6,114271,6.4,1977,1981,Malignant haematopoietic diseases,Greenland
304,2,1,510,7,10,114271,11.92,1977,1981,"Lip, oral cavity and pharynx",Greenland
304,2,1,520,5,12,114271,18.51,1977,1981,Colorectal,Greenland
304,2,10,10,46,0,132212,0,2016,2020,Lip,Greenland
304,2,10,20,19,8,132212,4.27,2016,2020,Oral Cavity,Greenland
304,2,10,30,22,6,132212,3.65,2016,2020,Salivary glands,Greenland
304,2,10,40,28,3,132212,1.87,2016,2020,Oropharynx,Greenland
304,2,10,41,24,5,132212,2.59,2016,2020,Nasopharynx,Greenland
304,2,10,50,29,3,132212,1.86,2016,2020,Hypopharynx,Greenland
304,2,10,60,14,13,132212,7.13,2016,2020,Oesophagus,Greenland
304,2,10,70,9,19,132212,10.5,2016,2020,Stomach,Greenland
304,2,10,80,34,2,132212,1.29,2016,2020,Small intestine,Greenland
304,2,10,110,18,8,132212,4.31,2016,2020,Liver,Greenland
304,2,10,120,16,7,132212,4.62,2016,2020,Gallbladder,Greenland
304,2,10,130,8,19,132212,10.91,2016,2020,Pancreas,Greenland
304,2,10,140,47,0,132212,0,2016,2020,"Nasal Cavity, middle ear and sinuses",Greenland
304,2,10,150,31,3,132212,1.82,2016,2020,Larynx,Greenland
304,2,10,160,3,118,132212,68.8,2016,2020,Lung,Greenland
304,2,10,170,48,0,132212,0,2016,2020,Pleura,Greenland
304,2,10,180,1,125,132212,73.49,2016,2020,Breast,Greenland
304,2,10,190,7,20,132212,14,2016,2020,Cervix uteri,Greenland
304,2,10,200,20,7,132212,3.92,2016,2020,Corpus uteri,Greenland
304,2,10,210,49,0,132212,0,2016,2020,"Uterus, other",Greenland
304,2,10,220,10,16,132212,9.03,2016,2020,Ovary and tubes,Greenland
304,2,10,227,50,0,132212,0,2016,2020,Vulva,Greenland
304,2,10,228,51,0,132212,0,2016,2020,Vagina,Greenland
304,2,10,229,41,1,132212,0.48,2016,2020,Other female genital organs,Greenland
304,2,10,230,42,1,132212,0.48,2016,2020,"Vulva, vagina and other female genital organs",Greenland
304,2,10,270,15,10,132212,5.73,2016,2020,Kidney,Greenland
304,2,10,280,21,7,132212,3.74,2016,2020,Bladder and urinary tract,Greenland
304,2,10,290,27,4,132212,1.9,2016,2020,Melanoma of skin,Greenland
304,2,10,300,43,1,132212,0.48,2016,2020,"Skin, non-melanoma",Greenland
304,2,10,310,39,1,132212,0.69,2016,2020,Eye,Greenland
304,2,10,315,52,0,132212,0,2016,2020,Endocrine tumors of brain and CNS,Greenland
304,2,10,316,25,4,132212,2.34,2016,2020,Meningiomas,Greenland
304,2,10,320,11,14,132212,8.53,2016,2020,Brain and CNS excluding endocrine tumors,Greenland
304,2,10,321,12,14,132212,8.53,2016,2020,Brain and CNS including endocrine tumors,Greenland
304,2,10,330,17,6,132212,4.32,2016,2020,Thyroid,Greenland
304,2,10,340,26,4,132212,2.24,2016,2020,Bone,Greenland
304,2,10,350,33,3,132212,1.54,2016,2020,Soft tissues,Greenland
304,2,10,360,13,14,132212,8.41,2016,2020,Non Hodgkin lymphomas,Greenland
304,2,10,370,37,1,132212,1,2016,2020,Hodgkin lymphomas,Greenland
304,2,10,380,30,4,132212,1.83,2016,2020,Multiple myelomas,Greenland
304,2,10,390,35,2,132212,1.28,2016,2020,Myelodysplastic syndromes,Greenland
304,2,10,392,45,1,132212,0.44,2016,2020,Myeloproliferative diseases,Greenland
304,2,10,394,53,0,132212,0,2016,2020,Other hematopoietic diseases,Greenland
304,2,10,400,23,6,132212,3.13,2016,2020,Leukaemias,Greenland
304,2,10,401,40,1,132212,0.58,2016,2020,Acute lymphatic leukaemias,Greenland
304,2,10,402,54,0,132212,0,2016,2020,Chronic lymphatic leukaemias,Greenland
304,2,10,403,44,1,132212,0.48,2016,2020,Other and unspecified lymphatic leukaemias,Greenland
304,2,10,404,38,2,132212,0.81,2016,2020,Acute myeloid leukaemias,Greenland
304,2,10,405,55,0,132212,0,2016,2020,Chronic myeloid leukaemias,Greenland
304,2,10,406,56,0,132212,0,2016,2020,Other and unspecified myeloid leukaemia,Greenland
304,2,10,407,36,2,132212,1.26,2016,2020,"Leukaemia, cell unspecified",Greenland
304,2,10,410,32,3,132212,1.68,2016,2020,Other specified cancers,Greenland
304,2,10,420,5,25,132212,15.11,2016,2020,Other and ill-defined cancers,Greenland
304,2,10,430,4,28,132212,16.08,2016,2020,Malignant haematopoietic diseases,Greenland
304,2,10,510,6,25,132212,14.24,2016,2020,"Lip, oral cavity and pharynx",Greenland
304,2,10,520,2,124,132212,69.88,2016,2020,Colorectal,Greenland
352,1,1,10,14,22,416277,5.22,1955,1959,Lip,Iceland
352,1,1,20,29,6,416277,1.31,1955,1959,Oral Cavity,Iceland
352,1,1,30,46,0,416277,0,1955,1959,Salivary glands,Iceland
352,1,1,40,41,2,416277,0.5,1955,1959,Oropharynx,Iceland
352,1,1,41,40,4,416277,0.95,1955,1959,Nasopharynx,Iceland
352,1,1,50,47,0,416277,0,1955,1959,Hypopharynx,Iceland
352,1,1,60,10,31,416277,7.24,1955,1959,Oesophagus,Iceland
352,1,1,70,1,308,416277,76.49,1955,1959,Stomach,Iceland
352,1,1,80,31,5,416277,1.28,1955,1959,Small intestine,Iceland
352,1,1,110,23,8,416277,1.99,1955,1959,Liver,Iceland
352,1,1,120,35,5,416277,1.19,1955,1959,Gallbladder,Iceland
352,1,1,130,13,27,416277,6.25,1955,1959,Pancreas,Iceland
352,1,1,140,33,5,416277,1.2,1955,1959,"Nasal Cavity, middle ear and sinuses",Iceland
352,1,1,150,24,8,416277,1.87,1955,1959,Larynx,Iceland
352,1,1,160,5,42,416277,10.84,1955,1959,Lung,Iceland
352,1,1,170,48,0,416277,0,1955,1959,Pleura,Iceland
352,1,1,180,43,1,416277,0.26,1955,1959,Breast,Iceland
352,1,1,240,2,69,416277,16.29,1955,1959,Prostate,Iceland
352,1,1,250,18,9,416277,2.21,1955,1959,Testis,Iceland
352,1,1,260,30,5,416277,1.29,1955,1959,Penis and other male genital organs,Iceland
352,1,1,270,8,30,416277,7.72,1955,1959,Kidney,Iceland
352,1,1,280,9,31,416277,7.62,1955,1959,Bladder and urinary tract,Iceland
352,1,1,290,44,1,416277,0.26,1955,1959,Melanoma of skin,Iceland
352,1,1,300,16,15,416277,3.42,1955,1959,"Skin, non-melanoma",Iceland
352,1,1,310,37,4,416277,1.11,1955,1959,Eye,Iceland
352,1,1,315,49,0,416277,0,1955,1959,Endocrine tumors of brain and CNS,Iceland
352,1,1,316,34,5,416277,1.2,1955,1959,Meningiomas,Iceland
352,1,1,320,11,27,416277,6.58,1955,1959,Brain and CNS excluding endocrine tumors,Iceland
352,1,1,321,12,27,416277,6.58,1955,1959,Brain and CNS including endocrine tumors,Iceland
352,1,1,330,19,8,416277,2.18,1955,1959,Thyroid,Iceland
352,1,1,340,22,8,416277,2.01,1955,1959,Bone,Iceland
352,1,1,350,21,8,416277,2.11,1955,1959,Soft tissues,Iceland
352,1,1,360,15,15,416277,3.78,1955,1959,Non Hodgkin lymphomas,Iceland
352,1,1,370,20,8,416277,2.16,1955,1959,Hodgkin lymphomas,Iceland
352,1,1,380,39,4,416277,1.05,1955,1959,Multiple myelomas,Iceland
352,1,1,390,50,0,416277,0,1955,1959,Myelodysplastic syndromes,Iceland
352,1,1,392,42,1,416277,0.27,1955,1959,Myeloproliferative diseases,Iceland
352,1,1,394,51,0,416277,0,1955,1959,Other hematopoietic diseases,Iceland
352,1,1,400,6,36,416277,8.41,1955,1959,Leukaemias,Iceland
352,1,1,401,38,5,416277,1.09,1955,1959,Acute lymphatic leukaemias,Iceland
352,1,1,402,32,5,416277,1.21,1955,1959,Chronic lymphatic leukaemias,Iceland
352,1,1,403,27,7,416277,1.61,1955,1959,Other and unspecified lymphatic leukaemias,Iceland
352,1,1,404,28,6,416277,1.4,1955,1959,Acute myeloid leukaemias,Iceland
352,1,1,405,45,1,416277,0.26,1955,1959,Chronic myeloid leukaemias,Iceland
352,1,1,406,26,7,416277,1.71,1955,1959,Other and unspecified myeloid leukaemia,Iceland
352,1,1,407,36,5,416277,1.13,1955,1959,"Leukaemia, cell unspecified",Iceland
352,1,1,410,25,7,416277,1.8,1955,1959,Other specified cancers,Iceland
352,1,1,420,17,10,416277,2.46,1955,1959,Other and ill-defined cancers,Iceland
352,1,1,430,3,64,416277,15.67,1955,1959,Malignant haematopoietic diseases,Iceland
352,1,1,510,7,34,416277,7.98,1955,1959,"Lip, oral cavity and pharynx",Iceland
352,1,1,520,4,52,416277,12.7,1955,1959,Colorectal,Iceland
352,1,10,10,43,9,896517,0.61,2016,2020,Lip,Iceland
352,1,10,20,29,29,896517,2.16,2016,2020,Oral Cavity,Iceland
352,1,10,30,36,14,896517,1.24,2016,2020,Salivary glands,Iceland
352,1,10,40,22,43,896517,3.53,2016,2020,Oropharynx,Iceland
352,1,10,41,45,5,896517,0.46,2016,2020,Nasopharynx,Iceland
352,1,10,50,49,2,896517,0.16,2016,2020,Hypopharynx,Iceland
352,1,10,60,17,93,896517,5.97,2016,2020,Oesophagus,Iceland
352,1,10,70,20,70,896517,4.43,2016,2020,Stomach,Iceland
352,1,10,80,35,23,896517,1.38,2016,2020,Small intestine,Iceland
352,1,10,110,18,83,896517,5.2,2016,2020,Liver,Iceland
352,1,10,120,30,33,896517,2.12,2016,2020,Gallbladder,Iceland
352,1,10,130,15,117,896517,7.29,2016,2020,Pancreas,Iceland
352,1,10,140,41,10,896517,0.82,2016,2020,"Nasal Cavity, middle ear and sinuses",Iceland
352,1,10,150,33,29,896517,1.7,2016,2020,Larynx,Iceland
352,1,10,160,4,389,896517,24.33,2016,2020,Lung,Iceland
352,1,10,170,39,17,896517,0.96,2016,2020,Pleura,Iceland
352,1,10,180,38,14,896517,0.98,2016,2020,Breast,Iceland
352,1,10,240,1,1048,896517,68.08,2016,2020,Prostate,Iceland
352,1,10,250,14,72,896517,7.48,2016,2020,Testis,Iceland
352,1,10,260,37,15,896517,1.04,2016,2020,Penis and other male genital organs,Iceland
352,1,10,270,7,184,896517,13.43,2016,2020,Kidney,Iceland
352,1,10,280,5,327,896517,20.2,2016,2020,Bladder and urinary tract,Iceland
352,1,10,290,13,110,896517,7.49,2016,2020,Melanoma of skin,Iceland
352,1,10,300,6,342,896517,18.13,2016,2020,"Skin, non-melanoma",Iceland
352,1,10,310,48,2,896517,0.17,2016,2020,Eye,Iceland
352,1,10,315,51,0,896517,0,2016,2020,Endocrine tumors of brain and CNS,Iceland
352,1,10,316,31,25,896517,1.81,2016,2020,Meningiomas,Iceland
352,1,10,320,8,156,896517,12.97,2016,2020,Brain and CNS excluding endocrine tumors,Iceland
352,1,10,321,9,156,896517,12.97,2016,2020,Brain and CNS including endocrine tumors,Iceland
352,1,10,330,26,38,896517,2.83,2016,2020,Thyroid,Iceland
352,1,10,340,42,6,896517,0.79,2016,2020,Bone,Iceland
352,1,10,350,34,20,896517,1.56,2016,2020,Soft tissues,Iceland
352,1,10,360,10,166,896517,12.3,2016,2020,Non Hodgkin lymphomas,Iceland
352,1,10,370,25,30,896517,3.02,2016,2020,Hodgkin lymphomas,Iceland
352,1,10,380,16,100,896517,6.02,2016,2020,Multiple myelomas,Iceland
352,1,10,390,24,53,896517,3.33,2016,2020,Myelodysplastic syndromes,Iceland
352,1,10,392,21,49,896517,3.78,2016,2020,Myeloproliferative diseases,Iceland
352,1,10,394,32,26,896517,1.77,2016,2020,Other hematopoietic diseases,Iceland
352,1,10,400,11,145,896517,11.89,2016,2020,Leukaemias,Iceland
352,1,10,401,23,22,896517,3.36,2016,2020,Acute lymphatic leukaemias,Iceland
352,1,10,402,19,70,896517,4.56,2016,2020,Chronic lymphatic leukaemias,Iceland
352,1,10,403,46,6,896517,0.42,2016,2020,Other and unspecified lymphatic leukaemias,Iceland
352,1,10,404,28,29,896517,2.27,2016,2020,Acute myeloid leukaemias,Iceland
352,1,10,405,40,14,896517,0.86,2016,2020,Chronic myeloid leukaemias,Iceland
352,1,10,406,47,2,896517,0.26,2016,2020,Other and unspecified myeloid leukaemia,Iceland
352,1,10,407,50,2,896517,0.15,2016,2020,"Leukaemia, cell unspecified",Iceland
352,1,10,410,44,7,896517,0.53,2016,2020,Other specified cancers,Iceland
352,1,10,420,27,45,896517,2.65,2016,2020,Other and ill-defined cancers,Iceland
352,1,10,430,2,569,896517,42.1,2016,2020,Malignant haematopoietic diseases,Iceland
352,1,10,510,12,102,896517,8.17,2016,2020,"Lip, oral cavity and pharynx",Iceland
352,1,10,520,3,469,896517,30.35,2016,2020,Colorectal,Iceland
352,2,1,10,48,0,409312,0,1955,1959,Lip,Iceland
352,2,1,20,34,5,409312,0.78,1955,1959,Oral Cavity,Iceland
352,2,1,30,35,4,409312,0.78,1955,1959,Salivary glands,Iceland
352,2,1,40,41,1,409312,0.25,1955,1959,Oropharynx,Iceland
352,2,1,41,31,4,409312,1.01,1955,1959,Nasopharynx,Iceland
352,2,1,50,46,1,409312,0.16,1955,1959,Hypopharynx,Iceland
352,2,1,60,14,25,409312,4.73,1955,1959,Oesophagus,Iceland
352,2,1,70,2,146,409312,29.62,1955,1959,Stomach,Iceland
352,2,1,80,33,4,409312,0.95,1955,1959,Small intestine,Iceland
352,2,1,110,28,6,409312,1.36,1955,1959,Liver,Iceland
352,2,1,120,26,7,409312,1.51,1955,1959,Gallbladder,Iceland
352,2,1,130,18,16,409312,3.15,1955,1959,Pancreas,Iceland
352,2,1,140,44,1,409312,0.22,1955,1959,"Nasal Cavity, middle ear and sinuses",Iceland
352,2,1,150,45,1,409312,0.22,1955,1959,Larynx,Iceland
352,2,1,160,12,24,409312,5.38,1955,1959,Lung,Iceland
352,2,1,170,49,0,409312,0,1955,1959,Pleura,Iceland
352,2,1,180,1,154,409312,36.24,1955,1959,Breast,Iceland
352,2,1,190,3,64,409312,15.53,1955,1959,Cervix uteri,Iceland
352,2,1,200,6,37,409312,8.96,1955,1959,Corpus uteri,Iceland
352,2,1,210,50,0,409312,0,1955,1959,"Uterus, other",Iceland
352,2,1,220,5,53,409312,12.46,1955,1959,Ovary and tubes,Iceland
352,2,1,227,23,8,409312,1.79,1955,1959,Vulva,Iceland
352,2,1,228,36,3,409312,0.7,1955,1959,Vagina,Iceland
352,2,1,229,51,0,409312,0,1955,1959,Other female genital organs,Iceland
352,2,1,230,20,11,409312,2.49,1955,1959,"Vulva, vagina and other female genital organs",Iceland
352,2,1,270,10,32,409312,7.26,1955,1959,Kidney,Iceland
352,2,1,280,16,17,409312,3.45,1955,1959,Bladder and urinary tract,Iceland
352,2,1,290,22,9,409312,2.17,1955,1959,Melanoma of skin,Iceland
352,2,1,300,30,6,409312,1.02,1955,1959,"Skin, non-melanoma",Iceland
352,2,1,310,38,2,409312,0.51,1955,1959,Eye,Iceland
352,2,1,315,52,0,409312,0,1955,1959,Endocrine tumors of brain and CNS,Iceland
352,2,1,316,17,15,409312,3.45,1955,1959,Meningiomas,Iceland
352,2,1,320,8,32,409312,7.74,1955,1959,Brain and CNS excluding endocrine tumors,Iceland
352,2,1,321,9,32,409312,7.74,1955,1959,Brain and CNS including endocrine tumors,Iceland
352,2,1,330,11,29,409312,7.12,1955,1959,Thyroid,Iceland
352,2,1,340,25,6,409312,1.54,1955,1959,Bone,Iceland
352,2,1,350,40,2,409312,0.46,1955,1959,Soft tissues,Iceland
352,2,1,360,21,10,409312,2.34,1955,1959,Non Hodgkin lymphomas,Iceland
352,2,1,370,27,6,409312,1.39,1955,1959,Hodgkin lymphomas,Iceland
352,2,1,380,37,3,409312,0.6,1955,1959,Multiple myelomas,Iceland
352,2,1,390,53,0,409312,0,1955,1959,Myelodysplastic syndromes,Iceland
352,2,1,392,54,0,409312,0,1955,1959,Myeloproliferative diseases,Iceland
352,2,1,394,55,0,409312,0,1955,1959,Other hematopoietic diseases,Iceland
352,2,1,400,15,16,409312,3.67,1955,1959,Leukaemias,Iceland
352,2,1,401,43,1,409312,0.23,1955,1959,Acute lymphatic leukaemias,Iceland
352,2,1,402,47,1,409312,0.11,1955,1959,Chronic lymphatic leukaemias,Iceland
352,2,1,403,32,4,409312,0.97,1955,1959,Other and unspecified lymphatic leukaemias,Iceland
352,2,1,404,56,0,409312,0,1955,1959,Acute myeloid leukaemias,Iceland
352,2,1,405,42,1,409312,0.24,1955,1959,Chronic myeloid leukaemias,Iceland
352,2,1,406,39,2,409312,0.5,1955,1959,Other and unspecified myeloid leukaemia,Iceland
352,2,1,407,24,7,409312,1.63,1955,1959,"Leukaemia, cell unspecified",Iceland
352,2,1,410,29,6,409312,1.36,1955,1959,Other specified cancers,Iceland
352,2,1,420,13,22,409312,4.87,1955,1959,Other and ill-defined cancers,Iceland
352,2,1,430,7,35,409312,7.99,1955,1959,Malignant haematopoietic diseases,Iceland
352,2,1,510,19,15,409312,2.98,1955,1959,"Lip, oral cavity and pharynx",Iceland
352,2,1,520,4,66,409312,12.55,1955,1959,Colorectal,Iceland
352,2,10,10,48,4,861955,0.2,2016,2020,Lip,Iceland
352,2,10,20,34,28,861955,1.43,2016,2020,Oral Cavity,Iceland
352,2,10,30,45,6,861955,0.45,2016,2020,Salivary glands,Iceland
352,2,10,40,43,8,861955,0.63,2016,2020,Oropharynx,Iceland
352,2,10,41,49,1,861955,0.16,2016,2020,Nasopharynx,Iceland
352,2,10,50,51,2,861955,0.12,2016,2020,Hypopharynx,Iceland
352,2,10,60,36,23,861955,1.33,2016,2020,Oesophagus,Iceland
352,2,10,70,20,57,861955,3.66,2016,2020,Stomach,Iceland
352,2,10,80,35,20,861955,1.34,2016,2020,Small intestine,Iceland
352,2,10,110,27,34,861955,2.01,2016,2020,Liver,Iceland
352,2,10,120,30,28,861955,1.76,2016,2020,Gallbladder,Iceland
352,2,10,130,18,100,861955,5.42,2016,2020,Pancreas,Iceland
352,2,10,140,47,4,861955,0.21,2016,2020,"Nasal Cavity, middle ear and sinuses",Iceland
352,2,10,150,44,6,861955,0.48,2016,2020,Larynx,Iceland
352,2,10,160,2,485,861955,29.2,2016,2020,Lung,Iceland
352,2,10,170,50,2,861955,0.16,2016,2020,Pleura,Iceland
352,2,10,180,1,1199,861955,89.48,2016,2020,Breast,Iceland
352,2,10,190,12,90,861955,8.47,2016,2020,Cervix uteri,Iceland
352,2,10,200,8,174,861955,11.76,2016,2020,Corpus uteri,Iceland
352,2,10,210,52,0,861955,0,2016,2020,"Uterus, other",Iceland
352,2,10,220,11,127,861955,8.5,2016,2020,Ovary and tubes,Iceland
352,2,10,227,29,29,861955,1.8,2016,2020,Vulva,Iceland
352,2,10,228,42,10,861955,0.65,2016,2020,Vagina,Iceland
352,2,10,229,53,0,861955,0,2016,2020,Other female genital organs,Iceland
352,2,10,230,24,39,861955,2.45,2016,2020,"Vulva, vagina and other female genital organs",Iceland
352,2,10,270,14,104,861955,6.94,2016,2020,Kidney,Iceland
352,2,10,280,15,111,861955,6.75,2016,2020,Bladder and urinary tract,Iceland
352,2,10,290,9,137,861955,10.74,2016,2020,Melanoma of skin,Iceland
352,2,10,300,7,288,861955,13.8,2016,2020,"Skin, non-melanoma",Iceland
352,2,10,310,41,9,861955,0.67,2016,2020,Eye,Iceland
352,2,10,315,54,0,861955,0,2016,2020,Endocrine tumors of brain and CNS,Iceland
352,2,10,316,17,72,861955,5.64,2016,2020,Meningiomas,Iceland
352,2,10,320,5,179,861955,15.31,2016,2020,Brain and CNS excluding endocrine tumors,Iceland
352,2,10,321,6,179,861955,15.31,2016,2020,Brain and CNS including endocrine tumors,Iceland
352,2,10,330,13,85,861955,7.6,2016,2020,Thyroid,Iceland
352,2,10,340,40,9,861955,0.84,2016,2020,Bone,Iceland
352,2,10,350,26,25,861955,2.08,2016,2020,Soft tissues,Iceland
352,2,10,360,10,133,861955,9.57,2016,2020,Non Hodgkin lymphomas,Iceland
352,2,10,370,28,17,861955,1.85,2016,2020,Hodgkin lymphomas,Iceland
352,2,10,380,19,77,861955,5.13,2016,2020,Multiple myelomas,Iceland
352,2,10,390,31,26,861955,1.57,2016,2020,Myelodysplastic syndromes,Iceland
352,2,10,392,23,37,861955,2.62,2016,2020,Myeloproliferative diseases,Iceland
352,2,10,394,38,18,861955,1.19,2016,2020,Other hematopoietic diseases,Iceland
352,2,10,400,16,90,861955,6.41,2016,2020,Leukaemias,Iceland
352,2,10,401,33,10,861955,1.48,2016,2020,Acute lymphatic leukaemias,Iceland
352,2,10,402,25,40,861955,2.23,2016,2020,Chronic lymphatic leukaemias,Iceland
352,2,10,403,46,5,861955,0.43,2016,2020,Other and unspecified lymphatic leukaemias,Iceland
352,2,10,404,37,20,861955,1.27,2016,2020,Acute myeloid leukaemias,Iceland
352,2,10,405,39,15,861955,1,2016,2020,Chronic myeloid leukaemias,Iceland
352,2,10,406,55,0,861955,0,2016,2020,Other and unspecified myeloid leukaemia,Iceland
352,2,10,407,56,0,861955,0,2016,2020,"Leukaemia, cell unspecified",Iceland
352,2,10,410,32,25,861955,1.52,2016,2020,Other specified cancers,Iceland
352,2,10,420,21,60,861955,3.11,2016,2020,Other and ill-defined cancers,Iceland
352,2,10,430,3,398,861955,28.34,2016,2020,Malignant haematopoietic diseases,Iceland
352,2,10,510,22,49,861955,2.98,2016,2020,"Lip, oral cavity and pharynx",Iceland
352,2,10,520,4,440,861955,26.88,2016,2020,Colorectal,Iceland
578,1,1,10,13,417,8526828,3.79,1953,1957,Lip,Norway
578,1,1,20,23,167,8526828,1.49,1953,1957,Oral Cavity,Norway
578,1,1,30,42,48,8526828,0.45,1953,1957,Salivary glands,Norway
578,1,1,40,33,84,8526828,0.77,1953,1957,Oropharynx,Norway
578,1,1,41,45,32,8526828,0.31,1953,1957,Nasopharynx,Norway
578,1,1,50,36,77,8526828,0.72,1953,1957,Hypopharynx,Norway
578,1,1,60,17,364,8526828,3.29,1953,1957,Oesophagus,Norway
578,1,1,70,1,4398,8526828,39.91,1953,1957,Stomach,Norway
578,1,1,80,39,62,8526828,0.6,1953,1957,Small intestine,Norway
578,1,1,110,35,76,8526828,0.75,1953,1957,Liver,Norway
578,1,1,120,40,64,8526828,0.59,1953,1957,Gallbladder,Norway
578,1,1,130,12,600,8526828,5.61,1953,1957,Pancreas,Norway
578,1,1,140,30,88,8526828,0.81,1953,1957,"Nasal Cavity, middle ear and sinuses",Norway
578,1,1,150,25,121,8526828,1.16,1953,1957,Larynx,Norway
578,1,1,160,6,900,8526828,8.74,1953,1957,Lung,Norway
578,1,1,170,47,10,8526828,0.1,1953,1957,Pleura,Norway
578,1,1,180,46,29,8526828,0.24,1953,1957,Breast,Norway
578,1,1,240,2,2908,8526828,25.01,1953,1957,Prostate,Norway
578,1,1,250,18,255,8526828,2.77,1953,1957,Testis,Norway
578,1,1,260,34,86,8526828,0.77,1953,1957,Penis and other male genital organs,Norway
578,1,1,270,16,352,8526828,3.44,1953,1957,Kidney,Norway
578,1,1,280,7,902,8526828,8.29,1953,1957,Bladder and urinary tract,Norway
578,1,1,290,22,189,8526828,1.85,1953,1957,Melanoma of skin,Norway
578,1,1,300,14,417,8526828,3.7,1953,1957,"Skin, non-melanoma",Norway
578,1,1,310,28,91,8526828,0.93,1953,1957,Eye,Norway
578,1,1,315,48,3,8526828,0.03,1953,1957,Endocrine tumors of brain and CNS,Norway
578,1,1,316,37,65,8526828,0.63,1953,1957,Meningiomas,Norway
578,1,1,320,11,623,8526828,6.61,1953,1957,Brain and CNS excluding endocrine tumors,Norway
578,1,1,321,10,626,8526828,6.64,1953,1957,Brain and CNS including endocrine tumors,Norway
578,1,1,330,32,85,8526828,0.79,1953,1957,Thyroid,Norway
578,1,1,340,26,93,8526828,1.11,1953,1957,Bone,Norway
578,1,1,350,27,104,8526828,1.07,1953,1957,Soft tissues,Norway
578,1,1,360,15,361,8526828,3.63,1953,1957,Non Hodgkin lymphomas,Norway
578,1,1,370,21,200,8526828,2.19,1953,1957,Hodgkin lymphomas,Norway
578,1,1,380,20,247,8526828,2.32,1953,1957,Multiple myelomas,Norway
578,1,1,390,49,0,8526828,0,1953,1957,Myelodysplastic syndromes,Norway
578,1,1,392,50,0,8526828,0,1953,1957,Myeloproliferative diseases,Norway
578,1,1,394,51,0,8526828,0,1953,1957,Other hematopoietic diseases,Norway
578,1,1,400,9,690,8526828,7.11,1953,1957,Leukaemias,Norway
578,1,1,401,44,35,8526828,0.39,1953,1957,Acute lymphatic leukaemias,Norway
578,1,1,402,29,94,8526828,0.89,1953,1957,Chronic lymphatic leukaemias,Norway
578,1,1,403,43,49,8526828,0.44,1953,1957,Other and unspecified lymphatic leukaemias,Norway
578,1,1,404,19,239,8526828,2.61,1953,1957,Acute myeloid leukaemias,Norway
578,1,1,405,31,82,8526828,0.8,1953,1957,Chronic myeloid leukaemias,Norway
578,1,1,406,41,63,8526828,0.58,1953,1957,Other and unspecified myeloid leukaemia,Norway
578,1,1,407,24,128,8526828,1.4,1953,1957,"Leukaemia, cell unspecified",Norway
578,1,1,410,38,61,8526828,0.61,1953,1957,Other specified cancers,Norway
578,1,1,420,5,1014,8526828,9.27,1953,1957,Other and ill-defined cancers,Norway
578,1,1,430,4,1498,8526828,15.25,1953,1957,Malignant haematopoietic diseases,Norway
578,1,1,510,8,825,8526828,7.54,1953,1957,"Lip, oral cavity and pharynx",Norway
578,1,1,520,3,1740,8526828,15.77,1953,1957,Colorectal,Norway
578,1,10,10,42,269,13381319,0.92,2016,2020,Lip,Norway
578,1,10,20,26,620,13381319,2.59,2016,2020,Oral Cavity,Norway
578,1,10,30,44,177,13381319,0.76,2016,2020,Salivary glands,Norway
578,1,10,40,21,864,13381319,3.94,2016,2020,Oropharynx,Norway
578,1,10,41,50,49,13381319,0.25,2016,2020,Nasopharynx,Norway
578,1,10,50,48,116,13381319,0.45,2016,2020,Hypopharynx,Norway
578,1,10,60,18,1188,13381319,4.63,2016,2020,Oesophagus,Norway
578,1,10,70,17,1417,13381319,5.24,2016,2020,Stomach,Norway
578,1,10,80,27,621,13381319,2.56,2016,2020,Small intestine,Norway
578,1,10,110,19,1101,13381319,4.3,2016,2020,Liver,Norway
578,1,10,120,31,550,13381319,2.07,2016,2020,Gallbladder,Norway
578,1,10,130,15,2209,13381319,8.05,2016,2020,Pancreas,Norway
578,1,10,140,46,133,13381319,0.56,2016,2020,"Nasal Cavity, middle ear and sinuses",Norway
578,1,10,150,35,433,13381319,1.64,2016,2020,Larynx,Norway
578,1,10,160,4,8499,13381319,30.64,2016,2020,Lung,Norway
578,1,10,170,41,325,13381319,1.02,2016,2020,Pleura,Norway
578,1,10,180,45,152,13381319,0.57,2016,2020,Breast,Norway
578,1,10,240,1,25412,13381319,97.1,2016,2020,Prostate,Norway
578,1,10,250,13,1487,13381319,10.3,2016,2020,Testis,Norway
578,1,10,260,37,337,13381319,1.33,2016,2020,Penis and other male genital organs,Norway
578,1,10,270,8,3078,13381319,13.16,2016,2020,Kidney,Norway
578,1,10,280,6,5911,13381319,20.61,2016,2020,Bladder and urinary tract,Norway
578,1,10,290,5,5808,13381319,24.13,2016,2020,Melanoma of skin,Norway
578,1,10,300,7,6556,13381319,20,2016,2020,"Skin, non-melanoma",Norway
578,1,10,310,40,211,13381319,1.04,2016,2020,Eye,Norway
578,1,10,315,43,151,13381319,0.81,2016,2020,Endocrine tumors of brain and CNS,Norway
578,1,10,316,33,390,13381319,1.82,2016,2020,Meningiomas,Norway
578,1,10,320,10,2230,13381319,11.77,2016,2020,Brain and CNS excluding endocrine tumors,Norway
578,1,10,321,9,2381,13381319,12.58,2016,2020,Brain and CNS including endocrine tumors,Norway
578,1,10,330,24,677,13381319,3.4,2016,2020,Thyroid,Norway
578,1,10,340,39,174,13381319,1.09,2016,2020,Bone,Norway
578,1,10,350,29,481,13381319,2.13,2016,2020,Soft tissues,Norway
578,1,10,360,11,2755,13381319,11.69,2016,2020,Non Hodgkin lymphomas,Norway
578,1,10,370,25,441,13381319,2.72,2016,2020,Hodgkin lymphomas,Norway
578,1,10,380,16,1484,13381319,5.6,2016,2020,Multiple myelomas,Norway
578,1,10,390,32,587,13381319,1.98,2016,2020,Myelodysplastic syndromes,Norway
578,1,10,392,22,937,13381319,3.89,2016,2020,Myeloproliferative diseases,Norway
578,1,10,394,36,434,13381319,1.61,2016,2020,Other hematopoietic diseases,Norway
578,1,10,400,12,2336,13381319,10.85,2016,2020,Leukaemias,Norway
578,1,10,401,28,220,13381319,2.24,2016,2020,Acute lymphatic leukaemias,Norway
578,1,10,402,20,1091,13381319,4.25,2016,2020,Chronic lymphatic leukaemias,Norway
578,1,10,403,47,135,13381319,0.54,2016,2020,Other and unspecified lymphatic leukaemias,Norway
578,1,10,404,30,465,13381319,2.08,2016,2020,Acute myeloid leukaemias,Norway
578,1,10,405,38,297,13381319,1.28,2016,2020,Chronic myeloid leukaemias,Norway
578,1,10,406,49,87,13381319,0.31,2016,2020,Other and unspecified myeloid leukaemia,Norway
578,1,10,407,51,36,13381319,0.13,2016,2020,"Leukaemia, cell unspecified",Norway
578,1,10,410,34,331,13381319,1.77,2016,2020,Other specified cancers,Norway
578,1,10,420,23,1043,13381319,3.53,2016,2020,Other and ill-defined cancers,Norway
578,1,10,430,3,8969,13381319,38.33,2016,2020,Malignant haematopoietic diseases,Norway
578,1,10,510,14,2095,13381319,8.9,2016,2020,"Lip, oral cavity and pharynx",Norway
578,1,10,520,2,11480,13381319,43.15,2016,2020,Colorectal,Norway
578,2,1,10,49,21,8609225,0.15,1953,1957,Lip,Norway
578,2,1,20,34,92,8609225,0.71,1953,1957,Oral Cavity,Norway
578,2,1,30,46,36,8609225,0.3,1953,1957,Salivary glands,Norway
578,2,1,40,41,59,8609225,0.45,1953,1957,Oropharynx,Norway
578,2,1,41,48,20,8609225,0.16,1953,1957,Nasopharynx,Norway
578,2,1,50,40,58,8609225,0.49,1953,1957,Hypopharynx,Norway
578,2,1,60,29,120,8609225,0.89,1953,1957,Oesophagus,Norway
578,2,1,70,2,3039,8609225,22.7,1953,1957,Stomach,Norway
578,2,1,80,45,47,8609225,0.37,1953,1957,Small intestine,Norway
578,2,1,110,44,49,8609225,0.4,1953,1957,Liver,Norway
578,2,1,120,23,187,8609225,1.46,1953,1957,Gallbladder,Norway
578,2,1,130,13,410,8609225,3.18,1953,1957,Pancreas,Norway
578,2,1,140,38,66,8609225,0.53,1953,1957,"Nasal Cavity, middle ear and sinuses",Norway
578,2,1,150,51,10,8609225,0.08,1953,1957,Larynx,Norway
578,2,1,160,22,216,8609225,1.82,1953,1957,Lung,Norway
578,2,1,170,52,2,8609225,0.02,1953,1957,Pleura,Norway
578,2,1,180,1,4273,8609225,37.03,1953,1957,Breast,Norway
578,2,1,190,3,1610,8609225,14.92,1953,1957,Cervix uteri,Norway
578,2,1,200,8,769,8609225,6.76,1953,1957,Corpus uteri,Norway
578,2,1,210,31,108,8609225,0.84,1953,1957,"Uterus, other",Norway
578,2,1,220,5,1175,8609225,10.59,1953,1957,Ovary and tubes,Norway
578,2,1,227,27,150,8609225,1.16,1953,1957,Vulva,Norway
578,2,1,228,36,66,8609225,0.55,1953,1957,Vagina,Norway
578,2,1,229,37,63,8609225,0.55,1953,1957,Other female genital organs,Norway
578,2,1,230,16,279,8609225,2.25,1953,1957,"Vulva, vagina and other female genital organs",Norway
578,2,1,270,14,316,8609225,2.82,1953,1957,Kidney,Norway
578,2,1,280,12,445,8609225,3.43,1953,1957,Bladder and urinary tract,Norway
578,2,1,290,20,228,8609225,2.11,1953,1957,Melanoma of skin,Norway
578,2,1,300,19,279,8609225,2.13,1953,1957,"Skin, non-melanoma",Norway
578,2,1,310,32,75,8609225,0.73,1953,1957,Eye,Norway
578,2,1,315,53,1,8609225,0.01,1953,1957,Endocrine tumors of brain and CNS,Norway
578,2,1,316,28,102,8609225,0.92,1953,1957,Meningiomas,Norway
578,2,1,320,10,548,8609225,5.51,1953,1957,Brain and CNS excluding endocrine tumors,Norway
578,2,1,321,9,549,8609225,5.52,1953,1957,Brain and CNS including endocrine tumors,Norway
578,2,1,330,18,250,8609225,2.14,1953,1957,Thyroid,Norway
578,2,1,340,33,65,8609225,0.73,1953,1957,Bone,Norway
578,2,1,350,30,94,8609225,0.85,1953,1957,Soft tissues,Norway
578,2,1,360,21,224,8609225,2.08,1953,1957,Non Hodgkin lymphomas,Norway
578,2,1,370,24,144,8609225,1.46,1953,1957,Hodgkin lymphomas,Norway
578,2,1,380,25,180,8609225,1.46,1953,1957,Multiple myelomas,Norway
578,2,1,390,54,0,8609225,0,1953,1957,Myelodysplastic syndromes,Norway
578,2,1,392,55,0,8609225,0,1953,1957,Myeloproliferative diseases,Norway
578,2,1,394,56,0,8609225,0,1953,1957,Other hematopoietic diseases,Norway
578,2,1,400,11,542,8609225,5.37,1953,1957,Leukaemias,Norway
578,2,1,401,50,8,8609225,0.1,1953,1957,Acute lymphatic leukaemias,Norway
578,2,1,402,39,60,8609225,0.51,1953,1957,Chronic lymphatic leukaemias,Norway
578,2,1,403,47,31,8609225,0.23,1953,1957,Other and unspecified lymphatic leukaemias,Norway
578,2,1,404,17,215,8609225,2.22,1953,1957,Acute myeloid leukaemias,Norway
578,2,1,405,35,70,8609225,0.63,1953,1957,Chronic myeloid leukaemias,Norway
578,2,1,406,43,46,8609225,0.41,1953,1957,Other and unspecified myeloid leukaemia,Norway
578,2,1,407,26,112,8609225,1.27,1953,1957,"Leukaemia, cell unspecified",Norway
578,2,1,410,42,45,8609225,0.45,1953,1957,Other specified cancers,Norway
578,2,1,420,7,1358,8609225,10.31,1953,1957,Other and ill-defined cancers,Norway
578,2,1,430,6,1090,8609225,10.37,1953,1957,Malignant haematopoietic diseases,Norway
578,2,1,510,15,286,8609225,2.26,1953,1957,"Lip, oral cavity and pharynx",Norway
578,2,1,520,4,1703,8609225,13.24,1953,1957,Colorectal,Norway
578,2,10,10,45,210,13171084,0.62,2016,2020,Lip,Norway
578,2,10,20,30,489,13171084,1.79,2016,2020,Oral Cavity,Norway
578,2,10,30,46,148,13171084,0.61,2016,2020,Salivary glands,Norway
578,2,10,40,37,285,13171084,1.28,2016,2020,Oropharynx,Norway
578,2,10,41,53,27,13171084,0.14,2016,2020,Nasopharynx,Norway
578,2,10,50,56,24,13171084,0.08,2016,2020,Hypopharynx,Norway
578,2,10,60,36,410,13171084,1.33,2016,2020,Oesophagus,Norway
578,2,10,70,23,851,13171084,2.88,2016,2020,Stomach,Norway
578,2,10,80,33,447,13171084,1.68,2016,2020,Small intestine,Norway
578,2,10,110,26,618,13171084,2.22,2016,2020,Liver,Norway
578,2,10,120,29,565,13171084,1.88,2016,2020,Gallbladder,Norway
578,2,10,130,16,1926,13171084,6.04,2016,2020,Pancreas,Norway
578,2,10,140,49,80,13171084,0.32,2016,2020,"Nasal Cavity, middle ear and sinuses",Norway
578,2,10,150,48,100,13171084,0.42,2016,2020,Larynx,Norway
578,2,10,160,3,8056,13171084,27.68,2016,2020,Lung,Norway
578,2,10,170,52,59,13171084,0.18,2016,2020,Pleura,Norway
578,2,10,180,1,17723,13171084,81.51,2016,2020,Breast,Norway
578,2,10,190,10,1819,13171084,10.98,2016,2020,Cervix uteri,Norway
578,2,10,200,6,3904,13171084,15.08,2016,2020,Corpus uteri,Norway
578,2,10,210,51,56,13171084,0.22,2016,2020,"Uterus, other",Norway
578,2,10,220,11,2269,13171084,9.52,2016,2020,Ovary and tubes,Norway
578,2,10,227,35,470,13171084,1.63,2016,2020,Vulva,Norway
578,2,10,228,47,111,13171084,0.44,2016,2020,Vagina,Norway
578,2,10,229,44,240,13171084,0.65,2016,2020,Other female genital organs,Norway
578,2,10,230,24,821,13171084,2.72,2016,2020,"Vulva, vagina and other female genital organs",Norway
578,2,10,270,17,1444,13171084,5.86,2016,2020,Kidney,Norway
578,2,10,280,15,1953,13171084,6.15,2016,2020,Bladder and urinary tract,Norway
578,2,10,290,5,5568,13171084,24.93,2016,2020,Melanoma of skin,Norway
578,2,10,300,8,5628,13171084,14.18,2016,2020,"Skin, non-melanoma",Norway
578,2,10,310,40,183,13171084,0.88,2016,2020,Eye,Norway
578,2,10,315,41,141,13171084,0.82,2016,2020,Endocrine tumors of brain and CNS,Norway
578,2,10,316,18,1059,13171084,5.08,2016,2020,Meningiomas,Norway
578,2,10,320,9,2665,13171084,13.64,2016,2020,Brain and CNS excluding endocrine tumors,Norway
578,2,10,321,7,2806,13171084,14.46,2016,2020,Brain and CNS including endocrine tumors,Norway
578,2,10,330,12,1619,13171084,9.11,2016,2020,Thyroid,Norway
578,2,10,340,42,124,13171084,0.8,2016,2020,Bone,Norway
578,2,10,350,31,381,13171084,1.75,2016,2020,Soft tissues,Norway
578,2,10,360,13,2095,13171084,8.05,2016,2020,Non Hodgkin lymphomas,Norway
578,2,10,370,27,315,13171084,2.15,2016,2020,Hodgkin lymphomas,Norway
578,2,10,380,21,1054,13171084,3.55,2016,2020,Multiple myelomas,Norway
578,2,10,390,39,380,13171084,1.13,2016,2020,Myelodysplastic syndromes,Norway
578,2,10,392,20,1024,13171084,3.98,2016,2020,Myeloproliferative diseases,Norway
578,2,10,394,38,334,13171084,1.17,2016,2020,Other hematopoietic diseases,Norway
578,2,10,400,14,1593,13171084,7.22,2016,2020,Leukaemias,Norway
578,2,10,401,34,154,13171084,1.67,2016,2020,Acute lymphatic leukaemias,Norway
578,2,10,402,25,675,13171084,2.31,2016,2020,Chronic lymphatic leukaemias,Norway
578,2,10,403,50,62,13171084,0.25,2016,2020,Other and unspecified lymphatic leukaemias,Norway
578,2,10,404,28,418,13171084,1.95,2016,2020,Acute myeloid leukaemias,Norway
578,2,10,405,43,181,13171084,0.74,2016,2020,Chronic myeloid leukaemias,Norway
578,2,10,406,55,45,13171084,0.13,2016,2020,Other and unspecified myeloid leukaemia,Norway
578,2,10,407,54,49,13171084,0.14,2016,2020,"Leukaemia, cell unspecified",Norway
578,2,10,410,32,356,13171084,1.72,2016,2020,Other specified cancers,Norway
578,2,10,420,22,1244,13171084,3.41,2016,2020,Other and ill-defined cancers,Norway
578,2,10,430,4,6786,13171084,27.22,2016,2020,Malignant haematopoietic diseases,Norway
578,2,10,510,19,1183,13171084,4.52,2016,2020,"Lip, oral cavity and pharynx",Norway
578,2,10,520,2,10715,13171084,35.55,2016,2020,Colorectal,Norway
752,1,1,10,20,716,18875469,2.57,1960,1964,Lip,Sweden
752,1,1,20,27,393,18875469,1.41,1960,1964,Oral Cavity,Sweden
752,1,1,30,39,161,18875469,0.66,1960,1964,Salivary glands,Sweden
752,1,1,40,45,128,18875469,0.47,1960,1964,Oropharynx,Sweden
752,1,1,41,41,145,18875469,0.56,1960,1964,Nasopharynx,Sweden
752,1,1,50,40,165,18875469,0.59,1960,1964,Hypopharynx,Sweden
752,1,1,60,22,717,18875469,2.51,1960,1964,Oesophagus,Sweden
752,1,1,70,2,7146,18875469,24.62,1960,1964,Stomach,Sweden
752,1,1,80,36,217,18875469,0.78,1960,1964,Small intestine,Sweden
752,1,1,110,21,716,18875469,2.55,1960,1964,Liver,Sweden
752,1,1,120,25,524,18875469,1.82,1960,1964,Gallbladder,Sweden
752,1,1,130,11,1974,18875469,6.86,1960,1964,Pancreas,Sweden
752,1,1,140,37,208,18875469,0.76,1960,1964,"Nasal Cavity, middle ear and sinuses",Sweden
752,1,1,150,24,517,18875469,1.92,1960,1964,Larynx,Sweden
752,1,1,160,5,4552,18875469,16.54,1960,1964,Lung,Sweden
752,1,1,170,47,58,18875469,0.21,1960,1964,Pleura,Sweden
752,1,1,180,46,97,18875469,0.34,1960,1964,Breast,Sweden
752,1,1,240,1,9190,18875469,29.84,1960,1964,Prostate,Sweden
752,1,1,250,23,462,18875469,2.32,1960,1964,Testis,Sweden
752,1,1,260,33,279,18875469,1.02,1960,1964,Penis and other male genital organs,Sweden
752,1,1,270,10,1960,18875469,7.16,1960,1964,Kidney,Sweden
752,1,1,280,6,2623,18875469,9.34,1960,1964,Bladder and urinary tract,Sweden
752,1,1,290,19,645,18875469,2.65,1960,1964,Melanoma of skin,Sweden
752,1,1,300,15,1243,18875469,4.29,1960,1964,"Skin, non-melanoma",Sweden
752,1,1,310,34,244,18875469,1.02,1960,1964,Eye,Sweden
752,1,1,315,49,25,18875469,0.13,1960,1964,Endocrine tumors of brain and CNS,Sweden
752,1,1,316,31,278,18875469,1.08,1960,1964,Meningiomas,Sweden
752,1,1,320,9,1721,18875469,7.44,1960,1964,Brain and CNS excluding endocrine tumors,Sweden
752,1,1,321,8,1746,18875469,7.58,1960,1964,Brain and CNS including endocrine tumors,Sweden
752,1,1,330,28,326,18875469,1.31,1960,1964,Thyroid,Sweden
752,1,1,340,32,213,18875469,1.05,1960,1964,Bone,Sweden
752,1,1,350,26,420,18875469,1.73,1960,1964,Soft tissues,Sweden
752,1,1,360,16,895,18875469,3.53,1960,1964,Non Hodgkin lymphomas,Sweden
752,1,1,370,17,709,18875469,3.12,1960,1964,Hodgkin lymphomas,Sweden
752,1,1,380,18,819,18875469,2.89,1960,1964,Multiple myelomas,Sweden
752,1,1,390,50,0,18875469,0,1960,1964,Myelodysplastic syndromes,Sweden
752,1,1,392,35,240,18875469,0.92,1960,1964,Myeloproliferative diseases,Sweden
752,1,1,394,43,126,18875469,0.51,1960,1964,Other hematopoietic diseases,Sweden
752,1,1,400,7,1980,18875469,8,1960,1964,Leukaemias,Sweden
752,1,1,401,44,129,18875469,0.51,1960,1964,Acute lymphatic leukaemias,Sweden
752,1,1,402,29,337,18875469,1.22,1960,1964,Chronic lymphatic leukaemias,Sweden
752,1,1,403,51,0,18875469,0,1960,1964,Other and unspecified lymphatic leukaemias,Sweden
752,1,1,404,38,164,18875469,0.69,1960,1964,Acute myeloid leukaemias,Sweden
752,1,1,405,42,141,18875469,0.55,1960,1964,Chronic myeloid leukaemias,Sweden
752,1,1,406,48,31,18875469,0.14,1960,1964,Other and unspecified myeloid leukaemia,Sweden
752,1,1,407,14,1178,18875469,4.9,1960,1964,"Leukaemia, cell unspecified",Sweden
752,1,1,410,30,281,18875469,1.2,1960,1964,Other specified cancers,Sweden
752,1,1,420,13,1648,18875469,5.97,1960,1964,Other and ill-defined cancers,Sweden
752,1,1,430,4,4769,18875469,18.96,1960,1964,Malignant haematopoietic diseases,Sweden
752,1,1,510,12,1708,18875469,6.26,1960,1964,"Lip, oral cavity and pharynx",Sweden
752,1,1,520,3,6844,18875469,23.88,1960,1964,Colorectal,Sweden
752,1,10,10,42,401,25511194,0.61,2016,2020,Lip,Sweden
752,1,10,20,24,1139,25511194,2.3,2016,2020,Oral Cavity,Sweden
752,1,10,30,43,259,25511194,0.55,2016,2020,Salivary glands,Sweden
752,1,10,40,19,1648,25511194,3.76,2016,2020,Oropharynx,Sweden
752,1,10,41,48,118,25511194,0.31,2016,2020,Nasopharynx,Sweden
752,1,10,50,47,229,25511194,0.42,2016,2020,Hypopharynx,Sweden
752,1,10,60,21,1848,25511194,3.22,2016,2020,Oesophagus,Sweden
752,1,10,70,17,2581,25511194,4.59,2016,2020,Stomach,Sweden
752,1,10,80,32,826,25511194,1.57,2016,2020,Small intestine,Sweden
752,1,10,110,16,2764,25511194,5.29,2016,2020,Liver,Sweden
752,1,10,120,28,1136,25511194,2.02,2016,2020,Gallbladder,Sweden
752,1,10,130,14,3819,25511194,6.9,2016,2020,Pancreas,Sweden
752,1,10,140,46,218,25511194,0.46,2016,2020,"Nasal Cavity, middle ear and sinuses",Sweden
752,1,10,150,34,732,25511194,1.35,2016,2020,Larynx,Sweden
752,1,10,160,7,10060,25511194,16.58,2016,2020,Lung,Sweden
752,1,10,170,41,440,25511194,0.66,2016,2020,Pleura,Sweden
752,1,10,180,44,284,25511194,0.52,2016,2020,Breast,Sweden
752,1,10,240,1,52130,25511194,96.56,2016,2020,Prostate,Sweden
752,1,10,250,15,1809,25511194,6.79,2016,2020,Testis,Sweden
752,1,10,260,35,707,25511194,1.27,2016,2020,Penis and other male genital organs,Sweden
752,1,10,270,12,4109,25511194,8.75,2016,2020,Kidney,Sweden
752,1,10,280,6,11584,25511194,18.51,2016,2020,Bladder and urinary tract,Sweden
752,1,10,290,4,10548,25511194,21.74,2016,2020,Melanoma of skin,Sweden
752,1,10,300,5,15843,25511194,21.73,2016,2020,"Skin, non-melanoma",Sweden
752,1,10,310,40,368,25511194,0.89,2016,2020,Eye,Sweden
752,1,10,315,51,22,25511194,0.08,2016,2020,Endocrine tumors of brain and CNS,Sweden
752,1,10,316,31,662,25511194,1.58,2016,2020,Meningiomas,Sweden
752,1,10,320,10,3390,25511194,9.36,2016,2020,Brain and CNS excluding endocrine tumors,Sweden
752,1,10,321,9,3412,25511194,9.44,2016,2020,Brain and CNS including endocrine tumors,Sweden
752,1,10,330,26,823,25511194,2.1,2016,2020,Thyroid,Sweden
752,1,10,340,39,268,25511194,0.93,2016,2020,Bone,Sweden
752,1,10,350,29,882,25511194,1.94,2016,2020,Soft tissues,Sweden
752,1,10,360,8,5083,25511194,9.96,2016,2020,Non Hodgkin lymphomas,Sweden
752,1,10,370,25,653,25511194,2.2,2016,2020,Hodgkin lymphomas,Sweden
752,1,10,380,18,2302,25511194,4.05,2016,2020,Multiple myelomas,Sweden
752,1,10,390,33,993,25511194,1.56,2016,2020,Myelodysplastic syndromes,Sweden
752,1,10,392,22,1444,25511194,2.92,2016,2020,Myeloproliferative diseases,Sweden
752,1,10,394,36,625,25511194,1.16,2016,2020,Other hematopoietic diseases,Sweden
752,1,10,400,11,4014,25511194,9.16,2016,2020,Leukaemias,Sweden
752,1,10,401,27,379,25511194,2.03,2016,2020,Acute lymphatic leukaemias,Sweden
752,1,10,402,20,1894,25511194,3.34,2016,2020,Chronic lymphatic leukaemias,Sweden
752,1,10,403,45,229,25511194,0.52,2016,2020,Other and unspecified lymphatic leukaemias,Sweden
752,1,10,404,30,833,25511194,1.79,2016,2020,Acute myeloid leukaemias,Sweden
752,1,10,405,38,468,25511194,1.05,2016,2020,Chronic myeloid leukaemias,Sweden
752,1,10,406,49,132,25511194,0.27,2016,2020,Other and unspecified myeloid leukaemia,Sweden
752,1,10,407,50,41,25511194,0.09,2016,2020,"Leukaemia, cell unspecified",Sweden
752,1,10,410,37,403,25511194,1.06,2016,2020,Other specified cancers,Sweden
752,1,10,420,23,1425,25511194,2.49,2016,2020,Other and ill-defined cancers,Sweden
752,1,10,430,3,15076,25511194,30.93,2016,2020,Malignant haematopoietic diseases,Sweden
752,1,10,510,13,3794,25511194,7.95,2016,2020,"Lip, oral cavity and pharynx",Sweden
752,1,10,520,2,17909,25511194,31.44,2016,2020,Colorectal,Sweden
752,2,1,10,48,65,18956501,0.2,1960,1964,Lip,Sweden
752,2,1,20,33,292,18956501,0.9,1960,1964,Oral Cavity,Sweden
752,2,1,30,37,184,18956501,0.71,1960,1964,Salivary glands,Sweden
752,2,1,40,49,55,18956501,0.17,1960,1964,Oropharynx,Sweden
752,2,1,41,47,97,18956501,0.32,1960,1964,Nasopharynx,Sweden
752,2,1,50,44,132,18956501,0.42,1960,1964,Hypopharynx,Sweden
752,2,1,60,32,385,18956501,1.12,1960,1964,Oesophagus,Sweden
752,2,1,70,6,4300,18956501,12.91,1960,1964,Stomach,Sweden
752,2,1,80,38,207,18956501,0.65,1960,1964,Small intestine,Sweden
752,2,1,110,30,478,18956501,1.47,1960,1964,Liver,Sweden
752,2,1,120,17,1109,18956501,3.29,1960,1964,Gallbladder,Sweden
752,2,1,130,13,1534,18956501,4.62,1960,1964,Pancreas,Sweden
752,2,1,140,43,132,18956501,0.44,1960,1964,"Nasal Cavity, middle ear and sinuses",Sweden
752,2,1,150,50,42,18956501,0.15,1960,1964,Larynx,Sweden
752,2,1,160,14,1167,18956501,3.78,1960,1964,Lung,Sweden
752,2,1,170,53,19,18956501,0.06,1960,1964,Pleura,Sweden
752,2,1,180,1,13201,18956501,46.28,1960,1964,Breast,Sweden
752,2,1,190,3,4071,18956501,16.73,1960,1964,Cervix uteri,Sweden
752,2,1,200,7,3324,18956501,11.55,1960,1964,Corpus uteri,Sweden
752,2,1,210,24,586,18956501,2.17,1960,1964,"Uterus, other",Sweden
752,2,1,220,4,3766,18956501,13.78,1960,1964,Ovary and tubes,Sweden
752,2,1,227,28,537,18956501,1.71,1960,1964,Vulva,Sweden
752,2,1,228,46,105,18956501,0.35,1960,1964,Vagina,Sweden
752,2,1,229,54,2,18956501,0.01,1960,1964,Other female genital organs,Sweden
752,2,1,230,25,644,18956501,2.07,1960,1964,"Vulva, vagina and other female genital organs",Sweden
752,2,1,270,12,1484,18956501,4.99,1960,1964,Kidney,Sweden
752,2,1,280,16,1116,18956501,3.49,1960,1964,Bladder and urinary tract,Sweden
752,2,1,290,19,754,18956501,3.05,1960,1964,Melanoma of skin,Sweden
752,2,1,300,22,729,18956501,2.24,1960,1964,"Skin, non-melanoma",Sweden
752,2,1,310,34,206,18956501,0.8,1960,1964,Eye,Sweden
752,2,1,315,51,20,18956501,0.1,1960,1964,Endocrine tumors of brain and CNS,Sweden
752,2,1,316,23,639,18956501,2.18,1960,1964,Meningiomas,Sweden
752,2,1,320,9,1839,18956501,7.39,1960,1964,Brain and CNS excluding endocrine tumors,Sweden
752,2,1,321,8,1859,18956501,7.5,1960,1964,Brain and CNS including endocrine tumors,Sweden
752,2,1,330,18,809,18956501,3.11,1960,1964,Thyroid,Sweden
752,2,1,340,36,165,18956501,0.75,1960,1964,Bone,Sweden
752,2,1,350,29,371,18956501,1.51,1960,1964,Soft tissues,Sweden
752,2,1,360,21,741,18956501,2.53,1960,1964,Non Hodgkin lymphomas,Sweden
752,2,1,370,26,465,18956501,1.9,1960,1964,Hodgkin lymphomas,Sweden
752,2,1,380,27,603,18956501,1.87,1960,1964,Multiple myelomas,Sweden
752,2,1,390,55,0,18956501,0,1960,1964,Myelodysplastic syndromes,Sweden
752,2,1,392,35,236,18956501,0.8,1960,1964,Myeloproliferative diseases,Sweden
752,2,1,394,40,126,18956501,0.46,1960,1964,Other hematopoietic diseases,Sweden
752,2,1,400,11,1432,18956501,5.58,1960,1964,Leukaemias,Sweden
752,2,1,401,45,87,18956501,0.36,1960,1964,Acute lymphatic leukaemias,Sweden
752,2,1,402,41,151,18956501,0.46,1960,1964,Chronic lymphatic leukaemias,Sweden
752,2,1,403,56,0,18956501,0,1960,1964,Other and unspecified lymphatic leukaemias,Sweden
752,2,1,404,39,140,18956501,0.52,1960,1964,Acute myeloid leukaemias,Sweden
752,2,1,405,42,127,18956501,0.45,1960,1964,Chronic myeloid leukaemias,Sweden
752,2,1,406,52,22,18956501,0.09,1960,1964,Other and unspecified myeloid leukaemia,Sweden
752,2,1,407,15,905,18956501,3.7,1960,1964,"Leukaemia, cell unspecified",Sweden
752,2,1,410,31,306,18956501,1.23,1960,1964,Other specified cancers,Sweden
752,2,1,420,10,1886,18956501,6.05,1960,1964,Other and ill-defined cancers,Sweden
752,2,1,430,5,3603,18956501,13.13,1960,1964,Malignant haematopoietic diseases,Sweden
752,2,1,510,20,825,18956501,2.72,1960,1964,"Lip, oral cavity and pharynx",Sweden
752,2,1,520,2,6144,18956501,19.54,1960,1964,Colorectal,Sweden
752,2,10,10,45,375,25277184,0.51,2016,2020,Lip,Sweden
752,2,10,20,27,1017,25277184,1.78,2016,2020,Oral Cavity,Sweden
752,2,10,30,44,275,25277184,0.64,2016,2020,Salivary glands,Sweden
752,2,10,40,35,621,25277184,1.42,2016,2020,Oropharynx,Sweden
752,2,10,41,50,57,25277184,0.16,2016,2020,Nasopharynx,Sweden
752,2,10,50,54,65,25277184,0.1,2016,2020,Hypopharynx,Sweden
752,2,10,60,38,709,25277184,1.13,2016,2020,Oesophagus,Sweden
752,2,10,70,23,1553,25277184,2.59,2016,2020,Stomach,Sweden
752,2,10,80,37,658,25277184,1.16,2016,2020,Small intestine,Sweden
752,2,10,110,24,1317,25277184,2.23,2016,2020,Liver,Sweden
752,2,10,120,25,1390,25277184,2.1,2016,2020,Gallbladder,Sweden
752,2,10,130,16,3743,25277184,6.08,2016,2020,Pancreas,Sweden
752,2,10,140,46,180,25277184,0.35,2016,2020,"Nasal Cavity, middle ear and sinuses",Sweden
752,2,10,150,47,166,25277184,0.33,2016,2020,Larynx,Sweden
752,2,10,160,5,11589,25277184,18.72,2016,2020,Lung,Sweden
752,2,10,170,52,102,25277184,0.15,2016,2020,Pleura,Sweden
752,2,10,180,1,36490,25277184,81.27,2016,2020,Breast,Sweden
752,2,10,190,10,2823,25277184,8.54,2016,2020,Cervix uteri,Sweden
752,2,10,200,7,6788,25277184,12.02,2016,2020,Corpus uteri,Sweden
752,2,10,210,33,833,25277184,1.5,2016,2020,"Uterus, other",Sweden
752,2,10,220,11,3479,25277184,7.58,2016,2020,Ovary and tubes,Sweden
752,2,10,227,32,1018,25277184,1.55,2016,2020,Vulva,Sweden
752,2,10,228,48,152,25277184,0.28,2016,2020,Vagina,Sweden
752,2,10,229,53,95,25277184,0.12,2016,2020,Other female genital organs,Sweden
752,2,10,230,26,1265,25277184,1.95,2016,2020,"Vulva, vagina and other female genital organs",Sweden
752,2,10,270,18,2090,25277184,4.37,2016,2020,Kidney,Sweden
752,2,10,280,14,4169,25277184,6.19,2016,2020,Bladder and urinary tract,Sweden
752,2,10,290,3,9796,25277184,22.1,2016,2020,Melanoma of skin,Sweden
752,2,10,300,6,12987,25277184,15.62,2016,2020,"Skin, non-melanoma",Sweden
752,2,10,310,42,340,25277184,0.76,2016,2020,Eye,Sweden
752,2,10,315,55,14,25277184,0.07,2016,2020,Endocrine tumors of brain and CNS,Sweden
752,2,10,316,19,1631,25277184,4.03,2016,2020,Meningiomas,Sweden
752,2,10,320,9,3697,25277184,9.99,2016,2020,Brain and CNS excluding endocrine tumors,Sweden
752,2,10,321,8,3711,25277184,10.06,2016,2020,Brain and CNS including endocrine tumors,Sweden
752,2,10,330,12,2326,25277184,6.91,2016,2020,Thyroid,Sweden
752,2,10,340,40,236,25277184,0.84,2016,2020,Bone,Sweden
752,2,10,350,34,647,25277184,1.49,2016,2020,Soft tissues,Sweden
752,2,10,360,13,3769,25277184,6.6,2016,2020,Non Hodgkin lymphomas,Sweden
752,2,10,370,28,488,25277184,1.76,2016,2020,Hodgkin lymphomas,Sweden
752,2,10,380,22,1679,25277184,2.66,2016,2020,Multiple myelomas,Sweden
752,2,10,390,39,672,25277184,0.93,2016,2020,Myelodysplastic syndromes,Sweden
752,2,10,392,21,1613,25277184,2.93,2016,2020,Myeloproliferative diseases,Sweden
752,2,10,394,41,485,25277184,0.83,2016,2020,Other hematopoietic diseases,Sweden
752,2,10,400,15,2773,25277184,6.17,2016,2020,Leukaemias,Sweden
752,2,10,401,31,297,25277184,1.6,2016,2020,Acute lymphatic leukaemias,Sweden
752,2,10,402,29,1126,25277184,1.72,2016,2020,Chronic lymphatic leukaemias,Sweden
752,2,10,403,49,83,25277184,0.18,2016,2020,Other and unspecified lymphatic leukaemias,Sweden
752,2,10,404,30,767,25277184,1.65,2016,2020,Acute myeloid leukaemias,Sweden
752,2,10,405,43,351,25277184,0.75,2016,2020,Chronic myeloid leukaemias,Sweden
752,2,10,406,51,83,25277184,0.16,2016,2020,Other and unspecified myeloid leukaemia,Sweden
752,2,10,407,56,25,25277184,0.05,2016,2020,"Leukaemia, cell unspecified",Sweden
752,2,10,410,36,557,25277184,1.29,2016,2020,Other specified cancers,Sweden
752,2,10,420,20,2430,25277184,3.51,2016,2020,Other and ill-defined cancers,Sweden
752,2,10,430,4,11438,25277184,21.82,2016,2020,Malignant haematopoietic diseases,Sweden
752,2,10,510,17,2410,25277184,4.61,2016,2020,"Lip, oral cavity and pharynx",Sweden
752,2,10,520,2,15936,25277184,25.26,2016,2020,Colorectal,Sweden
